Samir M. Hanash, M.D., Ph.D.

Peer-Reviewed Articles

1. Katayama H, Fahrmann JF, Olsen C, Irajizad E, Cai Y, Hsiao F, Dennison JB, Perrier ND, Hanash SM. Blood-Based Immunoglobulin-Bound Neoantigen Signatures Associated with MEN Type 1-Related Duodenopancreatic Neuroendocrine Tumor Progression. J Am Coll Surg 242(4):834-842, 2026. e-Pub 2026. PMID: 41562477.
2. Dennison, JB, Gendarme, S, Kettner, NM, Godoy, MC, Philley, JV, Antonoff, MB, Adams, M, Grainger, AV, Shersher, DD, Putnam, JB, Lee, C, Ryu, RK, Fan, AC, Chouaid, C, Maitre, B, Carballo, N, Ostrin, EJ, Hanash, S. The LEAP Study. Cancer Epidemiology Biomarkers and Prevention 35(1):39-48, 2026. e-Pub 2026. PMID: 41191414.
3. Fan, Y, Vykoukal, JV, Song, S, Pizzi, M, Zou, G, Yoshimura, K, Jin, J, Katayama, H, Calin, GA, Waters, R, Gan, Q, Wang, L, Hanash, S, Dhar, SS, Ajani, JA. Protocol for isolating patient-derived ascites cells and extracellular vesicles from gastric cancer peritoneal metastases. STAR Protocols 6(4), 2025. e-Pub 2025. PMID: 41105517.
4. Chen Y, Dou R, Hong MJ, Xu H, Vykoukal J, Leon-Letelier RA, Cai Y, Park S, Irajizad E, Hsiao FC, Dennison JB, Ostrin EJ, Fahrmann JF, Katayama H, Hanash SM. Lung adenocarcinoma surfaceome remodeling with EGFR inhibitors uncovers placental alkaline phosphatase as a target for combination therapy. Cell Rep Med 6(12), 2025. e-Pub 2025. PMID: 41406940.
5. Vykoukal, JV, Chen, Y, Zuo, M, Ballaro, R, Hong, MJ, Krishna, H, Rodriquez-Perera, DB, Katayama, H, Irajizad, E, Wu, R, Leon Letelier, R, Dennison, JB, Gutierrez, AM, Paulucci-Holthauzen, A, Thompson, T, Rusling, LA, Cai, Y, Hsiao, FC, Park, S, Arun, BK, Hanash, S, Fahrmann, JF. Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancer. Cell Reports Medicine 6(12), 2025. e-Pub 2025. PMID: 41406946.
6. Rudsari, HK, Khorami-Sarvestani, S, Fahrmann, JF, Long, JP, Hanash, S, Do, K, Irajizad, E. SMAGS-LASSO. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 34(12):2259-2266, 2025. e-Pub 2025. PMID: 40996315.
7. Theardy, MS, Takeda, M, Sorokin, A, Chen, S, Yang, Z, Wang, X, Kanikarla, PM, Coker, O, Nguyen, P, Wei, Y, Yao, J, Yan, L, Jin, Y, Cai, Y, Paku, M, Chen, Z, Li, KZ, Citron, F, Tomihara, H, Gao, S, Deem, AK, Zhao, J, Wang, H, Hanash, S, DePinho, RA, Maitra, A, Draetta, G, Ying, H, Kopetz, S, Yao, W. Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers. Cell Reports Medicine 6(8), 2025. e-Pub 2025. PMID: 40713971.
8. Liu, C, Mosley, A, Irajizad, E, Yip-Schneider, MT, Wu, H, Smith-Kinnaman, WR, Tran, T, Long, JP, Do, K, Fahrmann, JF, Dewitt, J, Hanash, S, Schmidt, CM, Zhang, J. Cyst fluid proteins stratify malignant risk of intraductal papillary mucinous neoplasm of the pancreas. Cancer Letters 624, 2025. e-Pub 2025. PMID: 40300662.
9. Liu C, Mosley A, Irajizad E, Yip-Schneider M, Wu H, Smith-Kinnaman WR, Tran T, Long JP, Do KA, Fahrmann J, DeWitt JM, Hanash S, Schmidt CM, Zhang J. Cyst fluid proteins stratify malignant risk of intraductal papillary mucinous neoplasm of the pancreas. Cancer Lett 624:217753, 2025. e-Pub 2025. PMID: 40300662.
10. Song, S, Fan, Y, Zou, G, Huo, L, Kumar, J, Li, Y, Wang, R, Dai, E, Jin, J, Scott, AW, Shao, SH, Pizzi, M, Vykoukal, JV, Katayama, H, Hanash, S, Calin, GA, Zhang, X, Lee, MG, Wang, Z, Lo, Y, Gan, Q, Waters, R, Yin, F, Wang, L, Cheng, X, Ajani, JA, Dhar, SS. KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPAB. Cancer Letters 621, 2025. e-Pub 2025. PMID: 40189014.
11. Leon Letelier, R, Chen, Y, Dou, R, Irajizad, E, Yip-Schneider, MT, Wu, R, Ejaz, R, Rudsari, HK, Li, Y, Spencer, R, Ballaro, R, Vykoukal, JV, Hurd, MW, Dennison, JB, Do, K, Maitra, A, Zhang, J, Hanash, S, Schmidt, CM, Fahrmann, JF. Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyamine Metabolism as a Biomarker of Progression. Clinical Cancer Research 31(12):2454-2465, 2025. e-Pub 2025. PMID: 40184234.
12. Zhu, B, Chen, P, Aminu, M, Li, J, Fujimoto, J, Tian, Y, Hong, L, Chen, H, Hu, X, Li, C, Vokes, N, Moreira, AL, Gibbons, DL, Solis Soto, LM, Parra Cuentas, ER, Shi, O, Diao, S, Ye, J, Rojas, FR, Vilar Sanchez, E, Maitra, A, Chen, K, Navin, N, Nilsson, M, Huang, B, Heeke, S, Zhang, J, Haymaker, CL, Velcheti, V, Sterman, DH, Kochat, V, Padron, WI, Alexandrov, LB, Wei, Z, Le, X, Wang, L, Fukuoka, J, Lee, JJ, Wistuba, II, Pass, HI, Davis, MM, Hanash, S, Cheng, C, Dubinett, SM, Spira, A, Rai, K, Lippman, SM, Futreal, A, Heymach, JV, Reuben, A, Wu, J, Zhang, J. Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception. Cancer cell 43(6):1125-1140.e10, 2025. e-Pub 2025. PMID: 40345189.
13. Leon Letelier, R, Sevillano-Mantas, AM, Chen, Y, Park, S, Vykoukal, JV, Fahrmann, JF, Ostrin, EJ, Garrett, C, Dou, R, Cai, Y, Hsiao, FC, Dennison, JB, Vilar Sanchez, E, Arun, BK, Hanash, S, Katayama, H. Citrullinated ENO1 Vaccine Enhances PD-1 Blockade in Mice Implanted with Murine Triple-Negative Breast Cancer Cells. Vaccines 13(6), 2025. e-Pub 2025. PMID: 40573960.
14. Gendarme S, Irajizad E, Long JP, Fahrmann JF, Dennison JB, Ghasemi SM, Dou R, Volk RJ, Meza R, Toumazis I, Canoui-Poitrine F, Hanash SM, Ostrin EJ. Impact of comorbidities on the mortality benefits of lung cancer screening: a post-hoc analysis of PLCO and NLST trials. J Thorac Oncol 20(5):565-576, 2025. e-Pub 2025. PMID: 39798695.
15. Chen Y, Ballaro R, Sans M, Thege FI, Zuo M, Dou R, Min J, Yip-Schneider M, Zhang J, Wu R, Irajizad E, Makino Y, Rajapakshe KI, Rudsari HK, Hurd MW, Leon-Letelier RA, Katayama H, Ostrin E, Vykoukal J, Dennison JB, Do KA, Hanash SM, Wolff RA, Guerrero PA, Kim M, Schmidt CM, Maitra A, Fahrmann JF. Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancers. Gut 74(10):1638-1652, 2025. e-Pub 2025. PMID: 40268349.
16. Jhaveri K, Thapa R, Ercan D, Saha A, Noble J, Singh P, Fahrmann J, Saini N, Wu R, Dennison JB, Hanash S, Jenq RR, Modi K, Figura N, Chavez J, Shah B, Nishihori T, Lazaryan A, Khimani F, Bachmeier C, Gage K, Mishra A, Perna F, Davila ML, Spiegel J, Rejeski K, Subklewe M, Locke FL, Freeman C, Parker N, Jain MD. Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B cell Lymphoma. Clin Cancer Res, 2025. e-Pub 2025. PMID: 40238583.
17. Ballaro, R, Wasylishen, A, Pieterman, CR, Olsen, C, Irajizad, E, Wu, R, Katayama, H, Liu, H, Cai, Y, Leon Letelier, R, Dennison, JB, Waguespack, SG, Do, K, Agarwal, SK, Walter, MF, Welch, JM, Weinstein, LS, Blau, J, Jha, S, Nilubol, N, Vriens, MR, Van Leeuwaarde, RS, Van Treijen, MJ, Valk, GD, Perrier, ND, Hanash, S, Fahrmann, JF. Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1. Cancer Letters 614, 2025. e-Pub 2025. PMID: 39924079.
18. Fahrmann JF, Yip-Schneider M, Vykoukal J, Spencer R, Dennison JB, Do KA, Long JP, Maitra A, Zhang J, Schmidt CM, Hanash S, Irajizad E. Lead time trajectory of blood-based protein biomarkers for detection of pancreatic cancer based on repeat testing. Cancer Lett 612:217450, 2025. e-Pub 2025. PMID: 39793753.
19. Prasad R, Rehman A, Rehman L, Darbaniyan F, Blumenberg V, Schubert ML, Mor U, Zamir E, Schmidt S, Hayase T, Chia-Chi C, McDaniel LK, Flores I, Strati P, Nair R, Chihara D, Fayad LE, Ahmed S, Iyer SP, Wang ML, Jain P, Nastoupil LJ, Westin JR, Arora R, Turner JG, Khawaja F, Wu R, Dennison JB, Menges M, Hidalgo-Vargas M, Reid KM, Davila ML, Dreger P, Korell F, Schmitt A, Tanner MR, Champlin RE, Flowers CR, Shpall EJ, Hanash S, Neelapu SS, Schmitt M, Subklewe M, Fahrmann J, Stein-Thoeringer C, Elinav E, Jain MD, Hayase E, Jenq RR, Saini NY. Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy. Blood 145(8):823-839, 2025. e-Pub 2024. PMID: 39441941.
20. Fan Y, Song S, Pizzi MP, Zou G, Vykoukal JV, Yoshimura K, Jin J, Calin GA, Waters RE, Gan Q, Wang L, Hanash S, Dhar SS, Ajani JA. Exosomal Galectin-3 promotes peritoneal metastases in gastric adenocarcinoma via microenvironment alterations. iScience 28(1):111564, 2025. e-Pub 2025. PMID: 39811647.
21. Fan, Y, Song, S, Pizzi, M, Zou, G, Vykoukal, JV, Yoshimura, K, Jin, J, Calin, GA, Waters, R, Gan, Q, Wang, L, Hanash, S, Dhar, SS, Ajani, JA. Exosomal Galectin-3 promotes peritoneal metastases in gastric adenocarcinoma via microenvironment alterations. iScience 28(1), 2025. e-Pub 2025. PMID: 39811647.
22. Gu C, Ghasemi SM, Cai Y, Fahrmann JF, Long JP, Katayama H, Wu C, Vykoukal J, Dennison JB, Hanash S, Do KA, Irajizad E. Grape-Pi: graph-based neural networks for enhanced protein identification in proteomics pipelines. Bioinform Adv 5(1):vbaf095, 2025. e-Pub 2025. PMID: 40406669.
23. Ghasemi SM, Gu C, Fahrmann JF, Hanash S, Do KA, Long JP, Irajizad E. A Novel Sensitivity Maximization at a Given Specificity Method for Binary Classifications. Cancer Prev Res (Phila). e-Pub 2024. PMID: 39618306.
24. Cheng X, Dai E, Wu J, Flores NM, Chu Y, Wang R, Dang M, Xu Z, Han G, Liu Y, Chatterjee D, Hu C, Ying J, Du Y, Yang L, Guan X, Mo S, Cao X, Pei G, Jiang J, Lu X, Benitez AM, Waters RE, Pizzi MP, Shanbhag N, Fan Y, Peng F, Hanash SM, Calin G, Futreal A, Song S, Yee C, Mazur PK, Qin JJ, Ajani JA, Wang L. Atlas of metastatic gastric cancer links ferroptosis to disease progression and immunotherapy response. Gastroenterology 167(7):1345-1357, 2024. e-Pub 2024. PMID: 39097198.
25. Gregg JR, Newcomb L, Wu R, Dennison J, Davis JW, Pettaway C, Pisters L, Ward JF, Chapin BF, Chéry L, Urkmez A, Fang AM, Higgason N, Troncoso P, Daniel CR, Logothetis C, Thompson TC, Hahn AW, Liu M, Zheng Y, Lin DW, Hanash S, Irajizad E, Fahrmann J. Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance. Biomark Res 12(1):134, 2024. e-Pub 2024. PMID: 39522029.
26. Haab, BB, Qian, L, Staal, B, Jain, M, Fahrmann, JF, Worthington, C, Prosser, D, Velokokhatnaya, L, Lopez, C, Tang, R, Hurd, MW, Natarajan, G, Kumar, S, Smith, L, Hanash, S, Batra, SK, Maitra, A, Lokshin, A, Huang, Y, Brand, RE. A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9 alone. Cancer Letters 604, 2024. e-Pub 2024. PMID: 39276915.
27. Gendarme, S, Maitre, B, Hanash, S, Pairon, JC, Canoui-Poitrine, F, Chouaid, C. Beyond lung cancer screening, an opportunity for early detection of chronic obstructive pulmonary disease and cardiovascular diseases. JNCI Cancer Spectrum 8(5), 2024. e-Pub 2024. PMID: 39270051.
28. Irajizad E, Fahrmann JF, Toumazis I, Vykoukal J, Dennison JB, Shen Y, Do KA, Ostrin EJ, Feng Z, Hanash S. Biomarker trajectory for earlier detection of lung cancer. EBioMedicine 108:105377, 2024. e-Pub 2024. PMID: 39353277.
29. Zheng Y, Wagner PD, Singal AG, Hanash SM, Srivastava S, Huang Y, Zhao YQ, Chari ST, Marquez G, Etizioni R, Marsh TL, Feng Z. Designing Rigorous and Efficient Clinical Utility Studies for Early Detection Biomarkers. Cancer Epidemiol Biomarkers Prev 33(9):1150-1157, 2024. e-Pub 2024. PMID: 39223980.
30. Fahrmann JF, Ghasemi SM, Han CY, Wu R, Dennison JB, Vykoukal J, Celestino J, Lu K, Lu Z, Drescher C, Do KA, Hanash S, Bast RC, Irajizad E. A metabolite-based liquid biopsy for detection of ovarian cancer. Biomark Res 12(1):91, 2024. e-Pub 2024. PMID: 39192316.
31. Takeda M, Theardy MS, Sorokin A, Coker O, Kanikarla P, Chen S, Yang Z, Nguyen P, Wei Y, Yao J, Wang X, Yan L, Jin Y, Cai Y, Paku M, Chen Z, Li KZ, Citron F, Tomihara H, Gao S, Deem AK, Zhao J, Wang H, Hanash S, DePinho RA, Maitra A, Draetta GF, Ying H, Kopetz S, Yao W. Therapeutic targeting of Syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers. bioRxiv, 2024. e-Pub 2024. PMID: 39211217.
32. Hemmati M, Ishizawa S, Meza R, Ostrin E, Hanash SM, Antonoff M, Schaefer AJ, Tammemagi MC, Toumazis I. Benchmarking lung cancer screening programmes with adaptive screening frequency against the optimal screening schedules derived from the ENGAGE framework: a comparative microsimulation study. EClinicalMedicine 74:102743, 2024. e-Pub 2024. PMID: 39764179.
33. Jansen SA, Cutilli A, de Koning C, van Hoesel M, Frederiks CL, Saiz Sierra L, Nierkens S, Mokry M, Nieuwenhuis EES, Hanash AM, Mocholi E, Coffer PJ, Lindemans CA. Chemotherapy-induced intestinal epithelial damage directly promotes galectin-9-driven modulation of T cell behavior. iScience 27(6):110072, 2024. e-Pub 2024. PMID: 38883813.
34. Song L, Irajizad E, Rundle A, Sesso HD, Gaziano JM, Vykoukal JV, Do KA, Dennison JB, Ostrin EJ, Fahrmann JF, Perera F, Hanash S. Validation of a Blood-Based Protein Biomarker Panel for a Risk Assessment of Lethal Lung Cancer in the Physicians' Health Study. Cancers (Basel) 16(11), 2024. e-Pub 2024. PMID: 38893188.
35. Haab B, Qian L, Staal B, Jain M, Fahrmann J, Worthington C, Prosser D, Velokokhatnaya L, Lopez C, Tang R, Hurd MW, Natarajan G, Kumar S, Smith L, Hanash S, Batra SK, Maitra A, Lokshin A, Huang Y, Brand RE. A Rigorous Multi-Laboratory Study of Known PDAC Biomarkers Identifies Increased Sensitivity and Specificity Over CA19-9 Alone. bioRxiv, 2024. e-Pub 2024. PMID: 38826212.
36. Ghasem SM, Fahrmann JF, Hanash S, Do KA, Long JP, Irajizad E. A novel method to guide biomarker combinations to optimize the sensitivity. bioRxiv, 2024. e-Pub 2024. PMID: 38659773.
37. Tai MC, Bantis LE, Parhy G, Kato T, Tanaka I, Chow CW, Fujimoto J, Behrens C, Hase T, Kawaguchi K, Fahrmann JF, Ostrin EJ, Yokoi K, Chen-Yoshikawa TF, Hasegawa Y, Hanash SM, Wistuba II, Taguchi A. Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma. Int J Mol Sci 25(4), 2024. e-Pub 2024. PMID: 38397007.
38. Faramand RG, Lee SB, Jain MD, Cao B, Wang X, Rejeski K, Subklewe M, Fahrmann JF, Saini NY, Hanash SM, Kang YP, Chang D, Rodriguez PC, Dean EA, Nishihori T, Shah BD, Lazaryan A, Chavez J, Khimani F, Pinilla-Ibarz JA, Dam M, Reid KM, Corallo SA, Menges M, Hidalgo Vargas M, Mandula JK, Holliday BA, Bachmeier CA, Speth K, Song Q, Mattie M, Locke FL, Davila ML. Baseline serum inflammatory proteins predict poor CAR T outcomes in diffuse large B-cell lymphoma. Blood Cancer Discov. e-Pub 2024. PMID: 38194367.
39. Hanash SM, Yu PP. Multicancer detection tests: What we know and what we don't know. CA Cancer J Clin 74(4):339-340, 2024. e-Pub 2024. PMID: 38517471.
40. Ben-Ami R, Wang QL, Zhang J, Supplee JG, Fahrmann JF, Lehmann-Werman R, Brais LK, Nowak J, Yuan C, Loftus M, Babic A, Irajizad E, Davidi T, Zick A, Hubert A, Neiman D, Piyanzin S, Gal-Rosenberg O, Horn A, Shemer R, Glaser B, Boos N, Jajoo K, Lee L, Clancy TE, Rubinson DA, Ng K, Chabot JA, Kastrinos F, Kluger M, Aguirre AJ, Jänne PA, Bardeesy N, Stanger B, O'Hara MH, Till J, Maitra A, Carpenter EL, Bullock AJ, Genkinger J, Hanash SM, Paweletz CP, Dor Y, Wolpin BM. Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer. Gut. e-Pub 2023. PMID: 38123998.
41. Zhang X, Irajizad E, Hoffman KL, Fahrmann JF, Li F, Seo YD, Browman GJ, Dennison JB, Vykoukal J, Luna PN, Siu W, Wu R, Murage E, Ajami NJ, McQuade JL, Wargo JA, Long JP, Do KA, Lampe JW, Basen-Engquist KM, Okhuysen PC, Kopetz S, bHanash SM, Petrosino JF, Scheet P, Daniel CR. Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial. EBioMedicine 98:104873, 2023. e-Pub 2023. PMID: 38040541.
42. Fan Y, Song S, Li Y, Dhar SS, Jin J, Yoshimura K, Yao X, Wang R, Scott AW, Pizzi MP, Wu J, Ma L, Calin GA, Hanash S, Wang L, Curran M, Ajani JA. Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T cell Immunity in Gastric Cancer Peritoneal Metastases. Cancer Res 83(22):3726-3738, 2023. e-Pub 2023. PMID: 37738407.
43. Deng N, Reyes-Uribe L, Fahrmann JF, Thoman WS, Munsell MF, Dennison JB, Murage E, Wu R, Hawk ET, Thirumurthi S, Lynch PM, Dieli-Conwright CM, Lazar AJ, Jindal S, Chu K, Chelvanambi M, Basen-Engquist K, Li Y, Wargo JA, McAllister F, Allison JP, Sharma P, Sinha KM, Hanash S, Gilchrist SC, Vilar E. Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-associated Immunity in Lynch Syndrome. Clin Cancer Res 29(21):4361-4372, 2023. e-Pub 2023. PMID: 37724990.
44. Geng C, Zhang MC, Manyam GC, Vykoukal JV, Fahrmann JF, Peng S, Wu C, Park S, Kondraganti S, Wang D, Robinson BD, Loda M, Barbieri CE, Yap TA, Corn PG, Hanash S, Broom BM, Pilié PG, Thompson TC. SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor-induced growth suppression. Clin Cancer Res 29(21):4464-4478, 2023. e-Pub 2023. PMID: 37581614.
45. Fahrmann JF, Wasylishen AR, Pieterman CRC, Irajizad E, Vykoukal J, Wu R, Dennison JB, Peterson CB, Zhao H, Do KA, Halperin DM, Agarwal SK, Blau JE, Jha S, Rivero JD, Nilubol N, Walter MF, Welch JM, Weinstein LS, Vriens MR, van Leeuwaarde RS, van Treijen MJC, Valk GD, Perrier ND, Hanash SM, Katayama H. Blood-based proteomic signatures associated with MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression. J Clin Endocrinol Metab 108(12):3260-3271, 2023. e-Pub 2023. PMID: 37307230.
46. Parks CG, Wilson LE, Capello M, Deane KD, Hanash SM. Tumor-Associated and Systemic Autoimmunity in Pre-Clinical Breast Cancer among Post-Menopausal Women. Biomolecules 13(11), 2023. e-Pub 2023. PMID: 38002248.
47. Irajizad E, Fahrmann JF, Marsh T, Vykoukal J, Dennison JB, Long JP, Do KA, Feng Z, Hanash S, Ostrin EJ. Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort. J Clin Oncol 41(27):4360-4368, 2023. e-Pub 2023. PMID: 37379494.
48. Irajizad E, Kenney A, Tang T, Vykoukal J, Wu R, Murage E, Dennison JB, Sans M, Long JP, Loftus M, Chabot JA, Kluger MD, Kastrinos F, Brais L, Babic A, Jajoo K, Lee LS, Clancy TE, Ng K, Bullock A, Genkinger JM, Maitra A, Do KA, Yu B, Wolpin BM, Hanash S, Fahrmann JF. A blood-based metabolomic signature predictive of risk for pancreatic cancer. Cell Rep Med 4(9):101194, 2023. e-Pub 2023. PMID: 37729870.
49. Sans M, Chen Y, Thege FI, Dou R, Min J, Yip-Schneider M, Zhang J, Wu R, Irajizad E, Makino Y, Rajapakshe KI, Hurd MW, León-Letelier RA, Vykoukal J, Dennison JB, Do KA, Wolff RA, Guerrero PA, Kim MP, Schmidt CM, Maitra A, Hanash S, Fahrmann JF. Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alteration. bioRxiv, 2023. e-Pub 2023. PMID: 37645752.
50. Wang R, Song S, Qin J, Yoshimura K, Peng F, Chu Y, Li Y, Fan Y, Jin J, Dang M, Dai E, Pei G, Han G, Hao D, Li Y, Chatterjee D, Harada K, Pizzi MP, Scott AW, Tatlonghari G, Yan X, Xu Z, Hu C, Mo S, Shanbhag N, Lu Y, Sewastjanow-Silva M, Fouad Abdelhakeem AA, Peng G, Hanash SM, Calin GA, Yee C, Mazur P, Marsden AN, Futreal A, Wang Z, Cheng X, Ajani JA, Wang L. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression. Cancer Cell 41(8):1407-1426.e9, 2023. e-Pub 2023. PMID: 37419119.
51. Gregg JR, Kim J, Logothetis C, Hanash S, Zhang X, Manyam G, Muir K, Group UC, Giles GG, Stanford JL, Berndt SI, Kogevinas M, Brenner H, Eeles RA, Consortium P, Wei P, Daniel CR. Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer. Eur Urol Oncol 6(3):282-288, 2023. e-Pub 2023. PMID: 35995710.
52. Liu S, Xie SM, Liu W, Gagea M, Hanker AB, Nguyen N, Singareeka Raghavendra A, Yang-Kolodji G, Chu F, Neelapu SS, Marchese A, Hanash S, Zimmermann J, Arteaga CL, Tripathy D. Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. Breast Cancer Res 25(1):62, 2023. e-Pub 2023. PMID: 37280713.
53. Ostrin EJ, Rider NL, Alousi AM, Irajizad E, Li L, Peng Q, Kim ST, Bashoura L, Arain MH, Noor LZ, Patel N, Mehta R, Popat UR, Hosing C, Jenq RR, Rondon G, Hanash SM, Paczesny S, Shpall EJ, Champlin RE, Dickey BF, Sheshadri A. A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept. Immunohorizons 7(6):421-430, 2023. e-Pub 2023. PMID: 37289498.
54. Zhao S, Wang R, Song S, Hao D, Han G, Song X, Zhang J, Pizzi MP, Shanbhag N, Futreal A, Badgwell B, Harada K, Calin G, Vykoukal J, Yu CY, Katayama H, Hanash SM, Wang L, Ajani JA. Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases. iScience 26(6):106913, 2023. e-Pub 2023. PMID: 37305699.
55. Fan Y, Li Y, Yao X, Jin J, Scott A, Liu B, Wang S, Huo L, Wang Y, Wang R, Pool Pizzi M, Ma L, Shao S, Sewastjanow-Silva M, Waters R, Chatterjee D, Liu B, Shanbhag N, Peng G, Calin GA, Mazur PK, Hanash SM, Ishizawa J, Hirata Y, Nagano O, Wang Z, Wang L, Xian W, McKeon F, Ajani JA, Song S. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment. Gut 72(4):624-637, 2023. e-Pub 2023. PMID: 36002248.
56. Liu S, Xie SM, Liu W, Gagea M, Hanker AB, Nguyen N, Raghavendra AS, Yang-Kolodji G, Chu F, Neelapu SS, Hanash S, Zimmermann J, Arteaga CL, Tripathy D. Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. Res Sq, 2023. e-Pub 2023. PMID: 36824840.
57. León-Letelier RA, Abdel Sater AH, Chen Y, Park S, Wu R, Irajizad E, Dennison JB, Katayama H, Vykoukal JV, Hanash S, Ostrin EJ, Fahrmann JF. Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis. Cancers (Basel) 15(3), 2023. e-Pub 2023. PMID: 36765792.
58. Fahrmann JF, Saini NY, Chia-Chi C, Irajizad E, Strati P, Nair R, Fayad LE, Ahmed S, Lee HJ, Iyer S, Steiner R, Vykoukal J, Wu R, Dennison JB, Nastoupil L, Jain P, Wang M, Green M, Westin J, Blumenberg V, Davila M, Champlin R, Shpall EJ, Kebriaei P, Flowers CR, Jain M, Jenq R, Stein-Thoeringer CK, Subklewe M, Neelapu SS, Hanash S. A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma. Cell Rep Med 3(11):100720, 2022. e-Pub 2022. PMID: 36384092.
59. Irajizad E, Han CY, Celestino J, Wu R, Murage E, Spencer R, Dennison JB, Vykoukal J, Long JP, Do KA, Drescher C, Lu K, Lu Z, Bast RC, Hanash S, Fahrmann JF. A blood-based metabolite panel for distinguishing ovarian cancer from benign pelvic masses. Clin Cancer Res 28(21):4669-4676, 2022. e-Pub 2022. PMID: 36037307.
60. Rigaud B, Weaver OO, Dennison JB, Awais M, Anderson BM, Chiang TD, Yang WT, Leung JWT, Hanash SM, Brock KK. Deep Learning Models for Automated Assessment of Breast Density Using Multiple Mammographic Image Types. Cancers (Basel) 14(20), 2022. e-Pub 2022. PMID: 36291787.
61. Vykoukal J, Fahrmann JF, Patel N, Shimizu M, Ostrin EJ, Dennison JB, Ivan C, Goodman GE, Thornquist MD, Barnett MJ, Feng Z, Calin GA, Hanash SM. Contributions of Circulating microRNAs for Early Detection of Lung Cancer. Cancers (Basel) 14(17), 2022. e-Pub 2022. PMID: 36077759.
62. Park S, Sater AHA, Fahrmann JF, Irajizad E, Cai Y, Katayama H, Vykoukal J, Kobayashi M, Dennison JB, Garcia-Manero G, Mullighan CG, Gu Z, Konopleva M, Hanash S. Novel UHRF1-MYC Axis in Acute Lymphoblastic Leukemia. Cancers (Basel) 14(17), 2022. e-Pub 2022. PMID: 36077796.
63. Yao S, Campbell PT, Ugai T, Gierach G, Abubakar M, Adalsteinsson V, Almeida J, Brennan P, Chanock S, Golub T, Hanash S, Harris C, Hathaway CA, Kelsey K, Landi MT, Mahmood F, Newton C, Quackenbush J, Rodig S, Schultz N, Tearney G, Tworoger SS, Wang M, Zhang X, Garcia-Closas M, Rebbeck TR, Ambrosone CB, Ogino S. Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting. Cancer Causes Control 33(8):1107-1120, 2022. e-Pub 2022. PMID: 35759080.
64. Irajizad E, Fahrmann JF, Long JP, Vykoukal J, Kobayashi M, Capello M, Yu CY, Cai Y, Hsiao FC, Patel N, Park S, Peng Q, Dennison JB, Kato T, Tai MC, Taguchi A, Kadara H, Wistuba II, Katayama H, Do KA, Hanash SM, Ostrin EJ. A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response. Int J Mol Sci 23(16), 2022. e-Pub 2022. PMID: 36012199.
65. Li YJ, Fahrmann JF, Aftabizadeh M, Zhao Q, Tripathi SC, Zhang C, Yuan Y, Ann D, Hanash S, Yu H. Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids. Cell Rep 39(13):111044, 2022. e-Pub 2022. PMID: 35767954.
66. Fahrmann JF, Tanaka I, Irajizad E, Mao X, Dennison JB, Murage E, Casabar J, Mayo J, Peng Q, Celiktas M, Vykoukal JV, Park S, Taguchi A, Delgado O, Tripathi SC, Katayama H, Soto LMS, Rodriguez-Canales J, Behrens C, Wistuba I, Hanash S, Ostrin EJ. Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma. Cancers (Basel) 14(10), 2022. e-Pub 2022. PMID: 35626147.
67. Li YJ, Fahrmann JF, Aftabizadeh M, Zhao Q, Tripathi SC, Zhang C, Yuan Y, Ann D, Hanash S, Yu H. Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids. Cell Rep 39(9):110870, 2022. e-Pub 2022. PMID: 35649368.
68. Fahrmann JF, Marsh T, Irajizad E, Patel N, Murage E, Vykoukal J, Dennison JB, Do KA, Ostrin E, Spitz MR, Lam S, Shete S, Meza R, Tammemägi MC, Feng Z, Hanash SM. Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. J Clin Oncol 40(8):876-883, 2022. e-Pub 2022. PMID: 34995129.
69. Chen Y, Capello M, Rios Perez MV, Vykoukal JV, Roife D, Kang Y, Prakash LR, Katayama H, Irajizad E, Fleury A, Ferri-Borgogno S, Baluya DL, Dennison JB, Do KA, Fiehn O, Maitra A, Wang H, Chiao PJ, Katz MHG, Fleming JB, Hanash SM, Fahrmann JF. CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop. Mol Metab 56:101426, 2022. e-Pub 2022. PMID: 34971802.
70. Tanaka I, Dayde D, Tai MC, Mori H, Solis LM, Tripathi SC, Fahrmann JF, Unver N, Parhy G, Jain R, Parra ER, Murakami Y, Aguilar-Bonavides C, Mino B, Celiktas M, Dhillon D, Casabar JP, Nakatochi M, Stingo F, Baladandayuthapani V, Wang H, Katayama H, Dennison JB, Lorenzi PL, Do KA, Fujimoto J, Behrens C, Ostrin EJ, Rodriguez-Canales J, Hase T, Fukui T, Kajino T, Kato S, Yatabe Y, Hosoda W, Kawaguchi K, Yokoi K, Chen-Yoshikawa TF, Hasegawa Y, Gazdar AF, Wistuba II, Hanash S, Taguchi A. SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas. J Natl Cancer Inst 114(2):290-301, 2022. e-Pub 2022. PMID: 34524427.
71. Capello M, Katayama H, Hanash SM. Proteomic Profiling of the Tumor Microenvironment. Methods Mol Biol 2435:157-167, 2022. e-Pub 2022. PMID: 34993945.
72. Irajizad E, Wu R, Vykoukal J, Murage E, Spencer R, Dennison JB, Moulder S, Ravenberg E, Lim B, Litton J, Tripathym D, Valero V, Damodaran S, Rauch GM, Adrada B, Candelaria R, White JB, Brewster A, Arun B, Long JP, Do KA, Hanash S, Fahrmann JF. Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Front Artif Intell 5:876100, 2022. e-Pub 2022. PMID: 36034598.
73. Fahrmann JF, Wasylishen AR, Pieterman CRC, Irajizad E, Vykoukal J, Murage E, Wu R, Dennison JB, Krishna H, Peterson CB, Lozano G, Zhao H, Do KA, Halperin DM, Agarwal SK, Blau JE, Del Rivero J, Nilubol N, Walter MF, Welch JM, Weinstein LS, Vriens MR, van Leeuwaarde RS, van Treijen MJC, Valk GD, Perrier ND, Hanash SM. A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression. J Clin Endocrinol Metab 106(12):e4969-e4980, 2021. e-Pub 2021. PMID: 34318891.
74. Hao D, He S, Harada K, Pizzi MP, Lu Y, Guan P, Chen L, Wang R, Zhang S, Sewastjanow-Silva M, Abdelhakeem A, Shanbhag N, Bhutani M, Han G, Lee JH, Zhao S, Weston B, Blum Murphy M, Waters R, Estrella JS, Roy-Chowdhuri S, Gan Q, Lee JS, Peng G, Hanash SM, Calin GA, Song X, Zhang J, Song S, Wang L, Ajani JA. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma. Gut 70(11):1-11, 2021. e-Pub 2021. PMID: 33334899.
75. Pandey A, Tripathi SC, Mai J, Hanash SM, Shen H, Mitra S, Rostomily RC. Combinatorial Effect of PLK1 Inhibition with Temozolomide and Radiation in Glioblastoma. Cancers (Basel) 13(20), 2021. e-Pub 2021. PMID: 34680264.
76. Zhu M, Peng R, Liang X, Lan Z, Tang M, Hou P, Song JH, Mak CSL, Park J, Zheng SE, Huang A, Ma X, Chen R, Chang Q, Logothetis CJ, Jain AK, Lin SH, Katayama H, Hanash S, Wang G. P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis. Oncogene 40(41):6049-6056, 2021. e-Pub 2021. PMID: 34471235.
77. Fahrmann JF, Katayama H, Irajizad E, Chakraborty A, Kato T, Mao X, Park S, Murage E, Rusling L, Yu CY, Cai Y, Hsiao FC, Dennison JB, Tran H, Ostrin E, Wilson DO, Yuan JM, Vykoukal J, Hanash S. Plasma Based Protein Signatures Associated with Small Cell Lung Cancer. Cancers (Basel) 13(16), 2021. e-Pub 2021. PMID: 34439128.
78. Dayde D, Gunther J, Hirayama Y, Weksberg DC, Boutin A, Parhy G, Aguilar-Bonavides C, Wang H, Katayama H, Abe Y, Do KA, Hara K, Kinoshita T, Komori K, Shimizu Y, Tajika M, Niwa Y, Wang YA, DePinho R, Hanash S, Krishnan S, Taguchi A. Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer. Cancers (Basel) 13(14), 2021. e-Pub 2021. PMID: 34298853.
79. Shu H, Chiang T, Wei P, Do KA, Lesslie MD, Cohen EO, Srinivasan A, Moseley TW, Chang Sen LQ, Leung JWT, Dennison JB, Hanash SM, Weaver OO. A Deep Learning Approach to Re-create Raw Full-Field Digital Mammograms for Breast Density and Texture Analysis. Radiol Artif Intell 3(4):e200097, 2021. e-Pub 2021. PMID: 34350403.
80. Katayama H, Kobayashi M, Irajizad E, Sevillarno A, Patel N, Mao X, Rusling L, Vykoukal J, Cai Y, Hsiao F, Yu CY, Long J, Liu J, Esteva F, Fahrmann J, Hanash S. Protein citrullination as a source of cancer neoantigens. J Immunother Cancer 9(6), 2021. e-Pub 2021. PMID: 34112737.
81. Stanton SE, Gad E, Ramos E, Corulli L, Annis J, Childs J, Katayama H, Hanash S Marks J, Disis ML. Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients. NPJ Breast Cancer 7(1):50, 2021. e-Pub 2021. PMID: 33976232.
82. Bommi PV, Bowen CM, Reyes-Uribe L, Wu W, Katayama H, Rocha P, Parra ER, Francisco-Cruz A, Ozcan Z, Tosti E, Willis JA, Wu H, Taggart MW, Burks JK, Lynch PM, Edelmann W, Scheet PA, Wistuba II, Sinha KM, Hanash SM, Vilar E. The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells. Cancer Res 81(10):2760-2773, 2021. e-Pub 2021. PMID: 34003775.
83. Ajani JA, Xu Y, Huo L, Wang R, Li Y, Wang Y, Pool Pizzi M, Scott A, Harada K, Ma L, Yao X, Jin J, Zhao W, dong X, Badgwell BD, Shanbhag N, Tatlonghari G, Estrella JS, Roy-Chowdhuri S, Kobayashi M, Vykoukal JV, Hanash SM, Calin GA, Peng G, Lee JS, Johnson RL, Wang Z, Wang L, Song S. YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition. Gut 70(1):55-66, 2021. e-Pub 2021. PMID: 32345613.
84. Bantis LE, Tsimikas JV, Chambers GR, Capello M, Hanash S, Feng Z. The length of the receiver operating characteristic curve and the two cutoff Youden index within a robust framework for discovery, evaluation, and cutoff estimation in biomarker studies involving improper receiver operating characteristic curves. Stat Med 40(7):1767-1789, 2021. e-Pub 2021. PMID: 33530129.
85. Fahrmann JF, Schmidt CM, Mao X, Irajizad E, Loftus M, Zhang J, Patel N, Vykoukal J, Dennison JB, Long JP, Do KA, Zhang J, Chabot JA, Kluger MD, Kastrinos F, Brais L, Babic A, Jajoo K, Lee LS, Clancy TE, Ng K, Bullock A, Genkinger J, Yip-Schneider MT, Maitra A, Wolpin BM, Hanash S. Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection. Gastroenterology S0016-5085(20):35546-3, 2021. e-Pub 2021. PMID: 33333055.
86. Ostrin EJ, Bantis LE, Wilson DO, Patel N, Wang R, Kundnani D, Adams-Haduch J, Dennison JB, Fahrmann JF, Chiu HT, Gazdar A, Feng Z, Yuan JM, Hanash SM. Contribution of a blood-based protein biomarker panel to the classification of indeterminate pulmonary nodules. J Thorac Oncol 16(2):228-236, 2021. e-Pub 2021. PMID: 33137463.
87. Fahrmann JF, Irajizad E, Kobayashi M, Vykoukal J, Dennison JB, Murage E, Wu R, Long JP, Do KA, Celestino J, Lu KH, Lu Z, Bast RC, Hanash S. A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer. Cancers (Basel) 13(4), 2021. e-Pub 2021. PMID: 33671595.
88. Wang R, Dang M, Harada K, Han G, Wang F, Pool Pizzi M, Zhao M, Tatlonghari G, Zhang S, Hao D, Lu Y, Zhao S, Badgwell BD, Blum Murphy M, Shanbhag N, Estrella JS, Roy-Chowdhuri S, Abdelhakeem AAF, Wang Y, Peng G, Hanash S, Calin GA, Song X, Chu Y, Zhang J, Li M, Chen K, Lazar AJ, Futreal A, Song S, Ajani JA, Wang L. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. Nat Med 27(1):141-151, 2021. e-Pub 2021. PMID: 33398161.
89. Liu Y, Kaur S, Huang Y, Fahrmann JF, Rinaudo JA, Hanash SM, Batra SK, Singhi AD, Brand RE, Maitra A, Haab BB. Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN. Cancer Epidemiol Biomarkers Prev 29(12):2513-2523, 2020. e-Pub 2020. PMID: 32532830.
90. Ostrin EJ, Sidransky D, Spira A, Hanash SM. Biomarkers for Lung Cancer Screening and Detection. Cancer Epidemiol Biomarkers Prev 29(12):2411-2415, 2020. e-Pub 2020. PMID: 33093160.
91. Chen B, Dragomir MP, Fabris L, Bayraktar R, Knutsen E, Liu X, Tang C, Li Y, Shimura T, Ivkovic TC, Cruz De Los Santos M, Anfossi S, Shimizu M, Shah MY, Ling H, Shen P, Multani AS, Pardini B, Burks JK, Katayama H, Reineke LC, Huo L, Syed M, Song S, Ferracin M, Oki E, Fromm B, Ivan C, Bhuvaneshwar K, Gusev Y, Mimori K, Menter D, Sen S, Matsuyama T, Uetake H, Vasilescu C, Kopetz S, Parker-Thornburg J, Taguchi A, Hanash SM, Girnita L, Slaby O, Goel A, Varani G, Gagea M, Li C, Ajani JA, Calin GA. The Long Noncoding RNA CCAT2 induces chromosomal instability through BOP1 - AURKB signaling. Gastroenterology 159(6):2146-2162, 2020. e-Pub 2020. PMID: 32805281.
92. Shimura T, Dayde D, Wang H, Okuda Y, Iwasaki H, Ebi M, Kitagawa M, Yamada T, Yamada T, Hanash SM, Taguchi A, Kataoka H. Novel urinary protein biomarker panel for early diagnosis of gastric cancer. Br J Cancer 123(11):1656-1664, 2020. e-Pub 2020. PMID: 32934343.
93. Zheng J, Hoffman KL, Chen JS, Shivappa N, Sood A, Browman GJ, Dirba DD, Hanash S, Wei P, Hebert JR, Petrosino JF, Schembre SM, Daniel CR. Dietary inflammatory potential in relation to the gut microbiome: results from a cross-sectional study. Br J Nutr 124(9):931-942, 2020. e-Pub 2020. PMID: 32475373.
94. Pichler M, Rodriguez-Aguayo C, Nam SY, Dragomir MP, Bayraktar R, Anfossi S, Knutsen E, Ivan C, Fuentes-Mattei E, Lee SK, Ling H, Catela Ivkovic T, Huang G, Huang L, Okugawa Y, Katayama H, Taguchi A, Bayraktar E, Bhattacharya R, Amero P, He WR, Tran AM, Vychytilova-Faltejskova P, Klec C, Bonilla DL, Zhang X, Kapitanovic S, Loncar B, Gafà R, Wang Z, Cristini V, Hanash SM, Bar-Eli M, Lanza G, Slaby O, Goel A, Rigoutsos I, Lopez-Berestein G, Calin GA. Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer. Gut 69(10):1818-1831, 2020. e-Pub 2020. PMID: 31988194.
95. Vykoukal J, Fahrmann JF, Gregg JR, Tang Z, Basourakos S, Irajizad E, Park S, Yang G, Creighton CJ, Fleury A, Mayo J, Paulucci-Holthauzen A, Dennison JB, Murage E, Peterson CB, Davis JW, Kim J, Hanash S, Thompson TC. Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer. Nat Commun 11(1):4279, 2020. e-Pub 2020. PMID: 32855410.
96. Srivastava S, Hanash S. Pan-Cancer Early Detection: Hype or Hope?. Cancer Cell 38(1):23-24, 2020. e-Pub 2020. PMID: 32531269.
97. Kato T, Fahrmann JF, Hanash SM, Vykoukal J. Extracellular Vesicles Mediate B Cell Immune Response and Are a Potential Target for Cancer Therapy. Cells 9(6):1518, 2020. e-Pub 2020. PMID: 32580358.
98. Inamoto Y, Martin PJ, Lee SJ, Momin AA, Tabellini L, Onstad LE, Pidala J, Flowers MED, Lawler RL, Katayama H, Hanash S, Hansen JA. Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantation. Blood Advances 4(11):2409-2417, 2020. e-Pub 2020. PMID: 32492155.
99. Fahrmann FF, Vykoukal J, Fleury A, Tripathi S, Dennison JB, Murage E, Wang P, Yu CY, Capello M, Creighton CJ, Do KA, Long JP, Irajizad E, Peterson C, Katayama H, Disis ML, Arun B, Hanash SM. Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer. JNCI Journal of the National Cancer Institute 112(6):607-616, 2020. e-Pub 2020. PMID: 31503278.
100. Fahrmann JF, Mao X, Irajizad E, Katayama H, Capello M, Tanaka I, Kato T, Wistuba I, Maitra A, Ostrin EJ, Hanash SM, Vykoukal J. Plasma-Derived Extracellular Vesicles Convey Protein Signatures that Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas. Cancers (Basel) 12(5):1147, 2020. e-Pub 2020. PMID: 32370304.
101. Capello M, Fahrmann JF, Rios-Perez MV, Vvykoukal J, Irajizad E, tripathi S, Roife D, Bantis LE, Kang Y, Kundnani D, Xu H, Prakash LR, Long JP, Katayama H, Fleury A, Borgogno SF, Baluya DL, Dennison JB, Aguilar-Benavides C, Casabar JP, Celiktas M, Do KA, Fiehn O, Maitra A, Wang H, Feng Z, Chiao PJ, Katz MH, Fleming JB, Hanash SM. CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes. JCO Precision Oncology(4):426-436, 2020. e-Pub 2020.
102. Rowan CM, Pike F, Cooke KR, Krance R, Carpenter PA, Duncan C, Jacobsohn DA, Bollard CM, Cruiz CRY, Malatpupre A, Farag SS, Renbarger J, Liu H, Bokoyannis G, Hanash S, Paczesny S. Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups. Blood 135(17):1428-1437, 2020. e-Pub 2020. PMID: 31972009.
103. Chekouo T, Stingo FC, Class CA, Yan Y, Bohannan Z, Wei Y, Garcia-Manero G, Hanash S, Do KA. Investigating protein patterns in human leukemia cell line experiments: A Bayesian approach for extremely small sample sizes. Stat Methods Med Res 29(4):1181-1196, 2020. e-Pub 2020. PMID: 31172886.
104. Chekouo T, Stingo FC, Class CA, Yan Y, Bohannan Z, Wei Y, Garcia-Manero G, Hanash S, Do KA. Investigating protein patterns in human leukemia cell line experiments: A Bayesian approach for extremely small sample sizes. Statistical Methods in Medical Research 29(4):1181-1196, 2020. e-Pub 2020. PMID: 31172886.
105. Mandili G, Follia L, Ferrero G, Katayama H, Hong W, Momin AA, Capello M, Giordano D, Spadi R, Satolli MA, Evangelista A, Hanash SM, Cordero F, Novelli F. Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients. Cancers (Basel) 12(3):746, 2020. e-Pub 2020. PMID: 32245227.
106. Taguchi A, Fahrmann JF, Hanash SM. A Promising CPS1 Inhibitor Keeping Ammonia from Fueling Cancer. Cell Chem Biol 27(3):253-254, 2020. e-Pub 2020. PMID: 32200911.
107. Yang WL, Lu Z, Guo J, Fellman BM, Ning J, Lu KH, Menon U, Kobayashi M, Hanash SM, Celestino J, Skates SJ, Bast RC. Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer. Cancer 126(4):725-736, 2020. e-Pub 2020. PMID: 31714597.
108. Kobayashi M, Katayama H, Irajizad E, Vykoukal JV, Fahrmann JF, Kundnani D, Yu CY, Cai Y, Hsiao FC, yang WL, Lu Z, Celestino J, Long JP, Do KA, Lu KH, Ladd JJ, Urban N, Jr BR, Hanash SM. Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis. Cancers (Basel) 12(2):485, 2020. e-Pub 2020. PMID: 32092936.
109. Wang R, Song S, Harada K, Ghazanfari Amlashi F, Badgwell B, Pizzi MP, Xu Y, Zhao W, Dong X, Jin J, Wang Y, Scott A, Ma L, Huo L, Vicente D, Blum Murphy M, Shanbhag N, Tatlonghari G, Thomas I, Rogers J, Kobayashi M, Vykoukal J, Estrella JS, Roy-Chowdhuri S, Han G, Zhang S, Mao X, Song X, Zhang J, Gu J, Johnson RL, Calin GA, Peng G, Lee JS, Hanash S, Futreal A, Wang Z, Wang L, Ajani JA. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut 69(1):18-31, 2020. e-Pub 2020. PMID: 31171626.
110. Subbalakshmi AR, Kundnani D, Biswas K, Ghosh A, Hanash SM, Tripathi SC, Jolly MK. NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype. Front Oncol 10:553342, 2020. e-Pub 2020. PMID: 33014880.
111. Zhang X, Browman G, Siu W, Basen-Engquist KM, Hanash SM, Hoffman KL, Okhuysen PC, Scheet P, Petrosino JF, Kopetz S, Daniel CR. The BE GONE trial study protocol: a randomized crossover dietary intervention of dry beans targeting the gut microbiome of overweight and obese patients with a history of colorectal polyps or cancer. BMC Cancer 19(1):1233, 2019. e-Pub 2019. PMID: 31852462.
112. Hanash SM, Feng Z, Taguchi A. Failure to Disclose Potential Conflict of Interest-Letter of Explanation. JAMA Oncol 5(12):1811, 2019. e-Pub 2019. PMID: 31725855.
113. Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, Scheet P, Xu H, Hanash SM, Feng L, Burks JK, Do KA, Peterson CB, Nejman D, Tzeng CD, Kim MP, Sears CL, Ajami N, Petrosino J, Wood LD, Maitra A, Straussman R, Katz M, White JR, Jenq R, Wargo J, McAllister F. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell 178(4):795-806.e12, 2019. e-Pub 2019. PMID: 31398337.
114. Bocci F, Tripathi SC, Vilchez Mercedes SA, George JT, Casabar JP, Wong PK, Hanash SM, Levine H, Onuchic JN, Jolly MK. NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype. Integr Biol (Camb) 11(6):251-263, 2019. e-Pub 2019. PMID: 31329868.
115. Liu X, Yue Z, Cao Y, Taylor L, Zhang Q, Choi SW, Hanash S, Ito S, Chen JY, Wu H, Paczesny S. Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology. JCO Precis Oncol 3, 2019. e-Pub 2019. PMID: 31406955.
116. Yao W, Rose JL, Wang W, Seth S, Jiang H, Taguchi A, Liu J, Yan L, Kapoor A, Hou P, Chen Z, Wang Q, Nezi L, Xu Z, Yao J, Hu B, Pettazzoni PF, Ho IL, Feng N, Ramamoorthy V, Jiang S, Deng P, Ma GJ, Den P, Tan Z, Zhang SX, Wang H, Wang YA, Deem AK, Fleming JB, Carugo A, Heffernan TP, Maitra A, Viale A, Ying H, Hanash S, DePinho RA, Draetta GF. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature 568(7752):410-414, 2019. e-Pub 2019. PMID: 30918400.
117. Fahrmann JF, Bantis LE, Capello M, Scelo G, Dennison JB, Patel N, Murage E, Vykoukal J, Kundnani DL, Foretova L, Fabianova E, Holcatova I, Janout V, Feng Z, Yip-Schneider M, Zhang J, Brand R, Taguchi A, Maitra A, Brennan P, Max Schmidt C, Hanash S. A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. J Natl Cancer Inst 111(4):372-379, 2019. e-Pub 2019. PMID: 30137376.
118. Yan Y, Sun N, Wang H, Kobayashi M, Ladd JJ, Long JP, Lo KC, Patel J, Sullivan E, Albert T, Goodman GE, Do KA, Hanash SM. Whole genome-derived tiled peptide arrays detect pre-diagnostic autoantibody signatures in non-small cell lung cancer. Cancer Res 79(7):1549-1557, 2019. e-Pub 2019. PMID: 30723114.
119. Capello M, Vykoukal JV, Katayama H, Bantis LE, Wang H, Kundnani DL, Aguilar-Bonavides C, Aguilar M, Tripathi SC, Dhillon DS, Momin AA, Peters H, Katz MH, Alvarez H, Bernard V, Ferri-Borgogno S, Brand R, Adler DG, Firpo MA, Mulvihill SJ, Molldrem JJ, Feng Z, Taguchi A, Maitra A, Hanash SM. Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. Nat Commun 10(1):254, 2019. e-Pub 2019. PMID: 30651550.
120. Jia D, George JT, Tripathi SC, Kundnani DL, Lu M, Hanash SM, Onuchic JN, Jolly MK, Levine H. Testing the gene expression classification of the EMT spectrum. Phys Biol 16(2):025002, 2019. e-Pub 2019. PMID: 30557866.
121. Katayama H, Tsou P, Kobayashi M, Capello M, Wang H, Esteva F, Disis ML, Hanash S. A plasma protein derived TGFβ signature is a prognostic indicator in triple negative breast cancer. NPJ Precis Oncol 3:10, 2019. e-Pub 2019. PMID: 30963111.
122. Follia L, Ferrero G, Mandili G, Beccuti M, Giordano D, Spadi R, Satolli MA, Evangelista A, Katayama H, Hong W, Momin AA, Capello M, Hanash SM, Novelli F, Cordero F. Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers. Front Oncol 9:115, 2019. e-Pub 2019. PMID: 30873387.
123. Cancer Etiology IAOL, Lung Cancer RCFEDO, Guida F, Sun N, Bantis LE, Muller DC, Li P, Taguchi A, Dhillon D, Kundnani DL, Patel NJ, Yan Q, Byrnes G, Moons KGM, Tjønneland A, Panico S, Agnoli C, Vineis P, Palli D, Bueno-de-Mesquita B, Peeters PH, Agudo A, Huerta JM, Dorronsoro M, Barranco MR, Ardanaz E, Travis RC, Byrne KS, Boeing H, Steffen A, Kaaks R, Hüsing A, Trichopoulou A, Lagiou P, La Vecchia C, Severi G, Boutron-Ruault MC, Sandanger TM, Weiderpass E, Nøst TH, Tsilidis K, Riboli E, Grankvist K, Johansson M, Goodman GE, Feng Z, Brennan P, Johansson M, Hanash SM. Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins. JAMA Oncol 4(10):e182078, 2018. e-Pub 2018. PMID: 30003238.
124. Jolly MK, Preca BT, Tripathi SC, Jia D, George JT, Hanash SM, Brabletz T, Stemmler MP, Maurer J, Levine H. Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer. APL Bioeng 2(3):031908, 2018. e-Pub 2018. PMID: 31069317.
125. Khosravi N, Caetano MS, Cumpian AM, Unver N, De la Garza Ramos C, Noble O, Daliri S, Hernandez BJ, Gutierrez BA, Evans SE, Hanash S, Alekseev AM, Yang Y, Chang SH, Nurieva R, Kadara H, Chen J, Ostrin EJ, Moghaddam SJ. IL22 Promotes Kras Mutant Lung Cancer by Induction of a Pro-Tumor Immune Response and Protection of Stemness Properties. Cancer Immunol Res 6(7):788-797, 2018. e-Pub 2018. PMID: 29764837.
126. Hanash S. The Wide World of Molecular Profiling for Tumor Classification. Clin Chem 64(4):743-744, 2018. e-Pub 2018. PMID: 29097505.
127. Unver N, Delgado O, Zeleke K, Cumpian A, Tang X, Caetano MS, Wang H, Katayama H, Yu H, Szabo E, Wistuba II, Moghaddam SJ, Hanash SM, Ostrin EJ. Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol. Int J Cancer 142(7):1405-1417, 2018. e-Pub 2018. PMID: 29134640.
128. Ostrin EJ, Little DR, Gerner-Mauro KN, Sumner EA, Ríos-Corzo R, Ambrosio E, Holt SE, Forcioli-Conti N, Akiyama H, Hanash SM, Kimura S, Huang SXL, Chen J. Beta-Catenin maintains lung epithelial progenitors after lung specification. Development 145(5), 2018. e-Pub 2018. PMID: 29440304.
129. Rho JH, Ladd JJ, Li CI, Potter JD, Zhang Y, Shelley D, Shibata D, Coppola D, Yamada H, Toyoda H, Tada T, Kumada T, Brenner DE, Hanash SM, Lampe PD. Protein and glycomic plasma markers for early detection of adenoma and colon cancer. Gut 67(3):473-484, 2018. e-Pub 2018. PMID: 27821646.
130. Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, Douville C, Javed AA, Wong F, Mattox A, Hruban RH, Wolfgang CL, Goggins MG, Dal Molin M, Wang TL, Roden R, Klein AP, Ptak J, Dobbyn L, Schaefer J, Silliman N, Popoli M, Vogelstein JT, Browne JD, Schoen RE, Brand RE, Tie J, Gibbs P, Wong HL, Mansfield AS, Jen J, Hanash SM, Falconi M, Allen PJ, Zhou S, Bettegowda C, Diaz LA, Tomasetti C, Kinzler KW, Vogelstein B, Lennon AM, Papadopoulos N. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359(6378):926-930, 2018. e-Pub 2018. PMID: 29348365.
131. Shiels MS, Kirk GD, Drummond MB, Dhillon D, Hanash SM, Taguchi A, Engels EA. HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D. J Infect Dis 217(3):413-417, 2018. e-Pub 2018. PMID: 29272472.
132. Wang T, Fahrmann JF, Lee H, Li YJ, Tripathi SC, Yue C, Zhang C, Lifshitz V, Song J, Yuan Y, Somlo G, Jandial R, Ann D, Hanash S, Jove R, Yu H. JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance. Cell Metab 27(1):136-150.e5, 2018. e-Pub 2018. PMID: 29249690.
133. Castillo J, Bernard V, San Lucas FA, Allenson K, Capello M, Kim DU, Gascoyne P, Mulu FC, Stephens BM, Huang J, Wang H, Momin AA, Jacamo RO, Katz M, Wolff R, Javle M, Varadhachary G, Wistuba II, Hanash S, Maitra A, Alvarez H. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Ann Oncol 29(1):223-229, 2018. e-Pub 2018. PMID: 29045505.
134. Basourakos SP, Davis JW, Chapin BF, Ward JF, Pettaway CA, Pisters LL, Navai N, Achim MF, Wang X, Chen HC, Choi S, Kuban D, Troncoso P, Hanash S, Thompson TC, Kim J. Baseline and Longitudinal Plasma Caveolin-1 Level as a Biomarker in Active Surveillance for Early Stage Prostate Cancer. BJU Int 121(1):69-76, 2018. e-Pub 2018. PMID: 28710901.
135. Bocci F, Jolly MK, Tripathi SC, Aguilar M, Hanash SM, Levine H, Onuchic JN. Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling. J R Soc Interface 14(136), 2017. e-Pub 2017. PMID: 29187638.
136. Vykoukal J, Sun N, Aguilar-Bonavides C, Katayama H, Tanaka I, Fahrmann JF, Capello M, Fujimoto J, Aguilar M, Wistuba II, Taguchi A, Ostrin EJ, Hanash SM. Plasma-derived extracellular vesicle proteins as a source of biomarkers for lung adenocarcinoma. Oncotarget 8(56):95466-95480, 2017. e-Pub 2017. PMID: 29221141.
137. Cohen JD, Javed AA, Thoburn C, Wong F, Tie J, Gibbs P, Schmidt CM, Yip-Schneider MT, Allen PJ, Schattner M, Brand RE, Singhi AD, Petersen GM, Hong SM, Kim SC, Falconi M, Doglioni C, Weiss MJ, Ahuja N, He J, Makary MA, Maitra A, Hanash SM, Dal Molin M, Wang Y, Li L, Ptak J, Dobbyn L, Schaefer J, Silliman N, Popoli M, Goggins MG, Hruban RH, Wolfgang CL, Klein AP, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Lennon AM. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proc Natl Acad Sci U S A 114(38):10202-10207, 2017. e-Pub 2017. PMID: 28874546.
138. Mbofung RM, McKenzie JA, Malu S, Zhang M, Peng W, Liu C, Kuiatse I, Tieu T, Williams L, Devi S, Ashkin E, Xu C, Huang L, Zhang M, Talukder AH, Tripathi SC, Khong H, Satani N, Muller FL, Roszik J, Heffernan T, Allison JP, Lizee G, Hanash SM, Proia D, Amaria R, Davis RE, Hwu P. HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes. Nat Commun 8(1):451, 2017. e-Pub 2017. PMID: 28878208.
139. Kodama M, Kodama T, Newberg JY, Katayama H, Kobayashi M, Hanash SM, Yoshihara K, Wei Z, Tien JC, Rangel R, Hashimoto K, Mabuchi S, Sawada K, Kimura T, Copeland NG, Jenkins NA. In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer. Proc Natl Acad Sci U S A 114(35):7301-7310. e-Pub 2017. PMID: 28811376.
140. Inamoto Y, Martin PJ, Paczesny S, Tabellini L, Momin AA, Mumaw CL, Flowers MED, Lee SJ, Carpenter PA, Storer BE, Hanash S, Hansen JA. Association of plasma CD163 concentration with de novo-onset chronic graft-versus-host disease. Biol Blood Marrow Transplant 23(8):1250-1256, 2017. e-Pub 2017. PMID: 28455006.
141. Schliekelman MJ, Creighton CJ, Baird BN, Chen Y, Banerjee P, Bota-Rabassedas N, Ahn YH, Roybal JD, Chen F, Zhang Y, Mishra DK, Kim MP, Liu X, Mino B, Villalobos P, Rodriguez-Canales J, Behrens C, Wistuba II, Hanash SM, Kurie JM. Thy-1(+) Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis. Sci Rep 7(1):6478, 2017. e-Pub 2017. PMID: 28744021.
142. Tripathi SC, Fahrmann JF, Celiktas M, Aguilar M, Marini KD, Jolly MK, Katayama H, Wang H, Murage EN, Dennison JB, Watkins DN, Levine H, Ostrin EJ, Taguchi A, Hanash SM. MCAM mediates chemoresistance in small cell lung cancer via the PI3K/AKT/SOX2 signaling pathway. Cancer Res 77(16):4414-4425. e-Pub 2017. PMID: 28646020.
143. Kerros C, Tripathi SC, Zha D, Mehrens JM, Sergeeva A, Philips AV, Qiao N, Peters HL, Katayama H, Sukhumalchandra P, Ruisaard KE, Perakis AA, St John LS, Lu S, Mittendorf EA, Clise-Dwyer K, Herrmann AC, Alatrash G, Toniatti C, Hanash SM, Ma Q, Molldrem JJ. Neuropilin-1 mediates Neutrophil Elastase uptake and cross-presentation in breast cancer cells. J Biol Chem 292(24):10295-10305. e-Pub 2017. PMID: 28468826.
144. Capello M, Bantis LE, Scelo G, Zhao Y, Li P, Dhillon DS, Patel NJ, Kundnani DL, Wang H, Abbruzzese JL, Maitra A, Tempero MA, Brand R, Brennan L, Feng E, Taguchi I, Janout V, Firpo MA, Mulvihill SJ, Katz MH, Hanash SM. Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. J Natl Cancer Inst 109(4), 2017. e-Pub 2017. PMID: 28376157.
145. Celiktas M, Tanaka I, Chandra Tripathi S, Fahrmann JF, Aguilar-Bonavides C, Villalobos P, Delgado O, Dhillon D, Dennison JB, Ostrin EJ, Wang H, Behrens C, Do KA, Gazdar AF, Hanash SM, Taguchi A. Role of CPS1 in Cell Growth, Metabolism, and Prognosis in LKB1-Inactivated Lung Adenocarcinoma. J Natl Cancer Inst 109(3), 2017. e-Pub 2017. PMID: 28034896.
146. Peters HL, Tripathi SC, Kerros C, Katayama H, Garber HR, St John LS, Federico L, Meraz IM, Roth JA, Sepesi B, Majidi M, Ruisaard K, Clise-Dwyer K, Roszik J, Gibbons DL, Heymach JV, Swisher SG, Bernatchez C, Alatrash G, Hanash SM, Molldrem JJ. Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells. Cancer Immunol Res 5(4):319-329. e-Pub 2017. PMID: 28254787.
147. Mustachio LM, Lu Y, Tafe LJ, Memoli V, Rodriguez-Canales J, Mino B, Villalobos PA, Wistuba I, Katayama H, Hanash SM, Roszik J, Kawakami M, Cho KJ, Hancock JF, Chinyengetere F, Hu S, Liu X, Freemantle SJ, Dmitrovsky E. Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer. Mol Cancer Res 15(7):905-914. e-Pub 2017. PMID: 28242811.
148. Allenson K, Castillo J, San Lucas FA, Scelo G, Kim DU, Bernard V, Davis G, Kumar T, Katz M, Overman MJ, Foretova L, Fabianova E, Holcatova I, Janout V, Meric-Bernstam F, Gascoyne P, Wistuba I, Varadhachary G, Brennan P, Hanash SM, Li D, Maitra A, Alvarez H. High Prevalence of Mutant KRAS in Circulating Exosome-derived DNA from Early Stage Pancreatic Cancer Patients. Ann Oncol 28(4):741-747. e-Pub 2017. PMID: 28104621.
149. Jia D, Jolly MK, Tripathi SC, Den Hollander P, Huang B, Lu M, Celiktas M, Ramirez-Peña E, Ben-Jacob E, Onuchic JN, Hanash SM, Mani SA, Levine H. Distinguishing mechanisms underlying EMT tristability. Cancer Converg 1(1):2, 2017. e-Pub 2017. PMID: 29623961.
150. Chen Y, Guo H, Terajima M, Banerjee P, Liu X, Yu J, Momin AA, Katayama H, Hanash SM, Burns AR, Fields GB, Yamauchi M, Kurie JM. Lysyl Hydroxylase 2 Is Secreted By Tumor Cells and Can Modify Collagen in the Extracellular Space. J Biol Chem 291(50):25799-25808, 2016. e-Pub 2016. PMID: 27803159.
151. Fu R, Wang P, Ma W, Taguchi A, Wong CH, Zhang Q, Gazdar A, Hanash SM, Zhou Q, Zhong H, Feng Z. A statistical method for detecting differentially expressed SNVs based on next-generation RNA-seq data. Biometrics 73(1):42-51. e-Pub 2016. PMID: 27276420.
152. Li W, Liu L, Gomez A, Zhang J, Ramadan A, Zhang Q, Choi SW, Zhang P, Greenson JK, Liu C, Jiang D, Virts E, Kelich SL, Chu HW, Flynn R, Blazar BR, Hanenberg H, Hanash SM, Paczesny S. Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease. JCI Insight 1(6), 2016. e-Pub 2016. PMID: 27195312.
153. Caetano MS, Zhang H, Cumpian AM, Gong L, Unver N, Ostrin EJ, Daliri S, Chang SH, Ochoa CE, Hanash SM, Behrens C, Wistuba II, Sternberg C, Kadara H, Ferreira CG, Watowich SS, Moghaddam SJ. IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer. Cancer Res 76(11):3189-3199. e-Pub 2016. PMID: 27197187.
154. Jolly MK, Tripathi SC, Jia D, Mooney SM, Celiktas M, Hanash SM, Mani SA, Pienta KJ, Ben-Jacob E, Levine H. Stability of the hybrid epithelial/mesenchymal phenotype. Oncotarget 7(19):27067-27084. e-Pub 2016. PMID: 27008704.
155. Redis RS, Vela LE, Lu W, Ferreira de Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B, Taguchi A, Chen Y, Fernandez AF, Valledor L, Van Roosbroeck K, Chang S, Shah M, Kinnebrew G, Han L, Atlasi Y, Cheung LH, Huang GY, Monroig P, Ramirez MS, Catela Ivkovic T, Van L, Ling H, Gafà R, Kapitanovic S, Lanza G, Bankson JA, Huang P, Lai SY, Bast RC, Rosenblum MG, Radovich M, Ivan M, Bartholomeusz G, Liang H, Fraga MF, Widger WR, Hanash SM, Berindan-Neagoe I, Lopez-Berestein G, Ambrosio AL, Gomes Dias SM, Calin GA. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell 61(4):520-34, 2016. e-Pub 2016. PMID: 26853146.
156. Tripathi SC, Peters HL, Taguchi A, Katayama H, Wang H, Momin A, Jolly MK, Celiktas M, Rodriguez-Canales J, Liu H, Behrens C, Wistuba II, Ben-Jacob E, Levine H, Molldrem JJ, Hanash SM, Ostrin EJ. Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. Proc Natl Acad Sci U S A 113(11):1555-1564. e-Pub 2016. PMID: 26929325.
157. Ruhaak LR, Stroble C, Dai J, Barnett MJ, Taguchi A, Goodman GE, Miyamoto S, Gandara DR, Feng Z, Lebrilla C, Hanash SM. Serum glycans as risk markers for non-small cell lung cancer. Cancer Prev Res (Phila) 9(4):317-323. e-Pub 2016. PMID: 26813970.
158. Lim SO, Li CW, Xia W, Lee HH, Chang SS, Shen J, Hsu JL, Raftery D, Djukovic D, Gu H, Chang WC, Wang HL, Chen ML, Huo L, Chen CH, Wu Y, Sahin A, Hanash SM, Hortobagyi GN, Hung MC. EGFR signaling enhances aerobic glycolysis in triple negative breast cancer cells to promote tumor growth and immune escape. Cancer Res 76(5):1284-1296. e-Pub 2016. PMID: 26759242.
159. Wang OH, Azizian N, Guo M, Capello M, Deng D, Zang F, Fry J, Katz MH, Fleming JB, Lee JE, Wolff RA, Hanash SM, Wang H, Maitra A. Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer. PLoS One 11(3):e0152300, 2016. e-Pub 2016. PMID: 27023625.
160. Zhang C, Suo J, Katayama H, Wei Y, Garcia-Manero G, Hanash SM. Quantitative proteomic analysis of histone modifications in decitabine sensitive and resistant leukemia cell lines. Clin Proteomics 13:14, 2016. e-Pub 2016. PMID: 27382363.
161. Hanash SM, Taguchi A, Wang H, Ostrin EJ. Deciphering the complexity of the cancer proteome for diagnostic applications. Expert Rev Mol Diagn 16(4):399-405. e-Pub 2015. PMID: 26694525.
162. Pankoval D, Chen Y, Terajima M, Schliekelman MJ, Baird BN, Fahrenholtz M, Sun L, Gill BJ, Vadakkan TJ, Kim MP, Ahn YH, Roybal JD, Liu X, Parra Cuentas ER, Rodriguez J, Wistuba II, Creighton CJ, Gibbons DL, Hicks JM, Dickinson ME, West JL, Grande-Allen KJ, Hanash SM, Yamauchi M, Kurie JM. Cancer-associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma. Mol Cancer Res 13(12):1-30. e-Pub 2015. PMID: 26631572.
163. Annesley T, Diamandis E, Bachmann L, Hanash SM, Hart B, Javahery R, Singh R, Smith R. A Spectrum of Views on Clinical Mass Spectrometry. Clin Chem 62(1):1-7. e-Pub 2015. PMID: 26553793.
164. Akil A, Zhang Q, Mumaw CL, Raiker N, Yu J, Velez de Mendizabal N, Haneline LS, Robertson KA, Skiles J, Diaz-Ricart M, Carreras E, Renbarger J, Hanash S, Bies RR, Paczesny S. Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 21(10):1739-45, 2015. e-Pub 2015. PMID: 26172478.
165. Taguchi A, Rho JH, Yan Q, Zhang Y, Zhao Y, Xu H, Tripathi SC, Wang H, Brenner DE, Kucherlapati M, Kucherlapati R, Boutin AT, Wang YA, DePinho RA, Feng Z, Lampe PD, Hanash SM. MAPRE1 as a Plasma Biomarker for Early-Stage Colorectal Cancer and Adenomas. Cancer Prev Res (Phila) 8(11):1112-1120. e-Pub 2015. PMID: 26342024.
166. Katayama H, Boldt C, Ladd JJ, Johnson MM, Chao T, Capello M, Suo J, Mao J, Manson JE, Prentice R, Esteva F, Wang H, Disis ML, Hanash S. An autoimmune response signature associated with the development of triple negative breast cancer reflects disease pathogenesis. Cancer Res 75(16):3246-54, 2015. e-Pub 2015. PMID: 26088128.
167. Capello M, Lee M, Wang H, Babel I, Katz MH, Fleming JB, Maitra A, Wang H, Tian W, Taguchi A, Hanash SM. Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma. J Natl Cancer Inst 107(8):1-9, 2015. e-Pub 2015. PMID: 26025324.
168. Wikoff WR, Hanash SM, DeFelice B, Miyamoto S, Barnett M, Zhao Y, Goodman G, Feng Z, Gandara D, Fiehn O, Taguchi A. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B. J Clin Oncol 33(33):3880-3887. e-Pub 2015. PMID: 26282655.
169. Schliekelman MJ, Taguchi A, Zhu J, Dai X, Rodriguez J, Celiktas M, Zhang Q, Chin A, Wong CH, Wang H, McFerrin L, Selamat SA, Yang C, Kroh EM, Garg KS, Behrens C, Gazdar AF, Laird-Offringa IA, Tewari M, Wistuba II, Thiery JP, Hanash SM. Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival. Cancer Res 75(9):1789-800, 2015. e-Pub 2015. PMID: 25744723.
170. Mischak H, Critselis E, Hanash SM, Gallagher WM, Vlahou A, Ioannidis JP. Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies. Am J Epidemiol 181(9):635-47, 2015. e-Pub 2015. PMID: 25792606.
171. Wang H, Hanash SM. Mass spectrometry based proteomics for absolute quantification of proteins from tumor cells. Methods 81:34-40. e-Pub 2015. PMID: 25794949.
172. Suo J, Medina D, Herrera S, Zheng ZY, Jin L, Chamness GC, Contreras A, Gutierrez C, Hilsenbeck S, Umar A, Foekens JA, Hanash SM, Schiff R, Zhang XH, Chang EC. Int6 reduction activates stromal fibroblasts to enhance transforming activity in breast epithelial cells. Cell Biosci 5(10):1-10, 2015. e-Pub 2015. PMID: 25774287.
173. Miyamoto S, Taylor SL, Barupal DK, Taguchi A, Wohlgemuth G, Wikoff WR, Yoneda KY, Gandara DR, Hanash SM, Kim K, Fiehn O. Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry. Metabolites 5(2):192-210, 2015. e-Pub 2015. PMID: 25859693.
174. Taguchi A, Delgado O, Celiktas M, Katayama H, Wang H, Gazdar AF, Hanash SM. Proteomic signatures associated with p53 mutational status in lung adenocarcinoma. Proteomics 14(23-24):2750-2759, 2014. e-Pub 2014. PMID: 25331784.
175. Lu M, Huang B, Hanash SM, Onuchic JN, Ben-Jacob E. Modeling putative therapeutic implications of exosome exchange between tumor and immune cells. Proc Natl Acad Sci U S A 111(40):E4165-74, 2014. e-Pub 2014. PMID: 25246552.
176. Taguchi A, Taylor AD, Rodriguez J, Celiktas M, Liu H, Ma X, Zhang Q, Wong CH, Chin A, Girard L, Behrens C, Lam WL, Lam S, Minna JD, Wistuba II, Gazdar AF, Hanash SM. A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes expanding the repertoire of potential immunotherapeutic targets. Cancer Res 74(17):4694-4705, 2014. e-Pub 2014. PMID: 24970476.
177. Peng G, Chun-Jen Lin C, Mo W, Dai H, Park YY, Kim SM, Peng Y, Mo Q, Siwko S, Hu R, Lee JS, Hennessy B, Hanash SM, Mills GB, Lin SY. Genome-wide transcriptome profiling of homologous recombination DNA repair. Nat Commun 5(3361):1-11, 2014. e-Pub 2014. PMID: 24553445.
178. Hanash SM, Taguchi A. Mouse to Human Blood-Based Cancer Biomarker Discovery Strategies. Cold Spring Harb Protoc 2014(2):144-149, 2014. e-Pub 2014. PMID: 24173314.
179. Mao J, Ladd J, Gad E, Rastetter L, Johnson MM, Marzbani E, Childs JS, Lu H, Dang Y, Broussard E, Stanton SE, Hanash SM, Disis ML. Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer. J Transl Med 12(121):1-10, 2014. e-Pub 2014. PMID: 24886063.
180. Hanash S, Schliekelman M. Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers. Genome Med 6(2):12, 2014. e-Pub 2014. PMID: 24713112.
181. Prentice RL, Zhao S, Johnson M, Aragaki A, Hsia J, Jackson RD, Rossouw JE, Manson JE, Hanash SM. Proteomic risk markers for coronary heart disease and stroke: Validation and mediation of randomized trial hormone therapy effects on these diseases. Genome Med 5(12):112. e-Pub 2013. PMID: 24373343.
182. Sin DD, Tammemagi CM, Lam S, Barnett MJ, Duan X, Tam A, Auman H, Feng Z, Goodman GE, Hanash S, Taguchi A. Pro-Surfactant Protein B as a Biomarker for Lung Cancer Prediction. J Clin Oncol 31(36):4536-43, 2013. e-Pub 2013. PMID: 24248694.
183. Tam KW, Zhang W, Soh J, Stastny V, Chen M, Sun H, Thu K, Rios JJ, Yang C, Marconett CN, Selamat SA, Laird-Offringa IA, Taguchi A, Hanash SM, Shames D, Ma X, Zhang MQ, Lam WL, Gazdar A. CDKN2A/p16 Inactivation Mechanisms and Their Relationship to Smoke Exposure and Molecular Features in Non-Small-Cell Lung Cancer. J Thorac Oncol 8(11):1378-88, 2013. e-Pub 2013. PMID: 24077454.
184. Ruhaak LR, Nguyen UT, Stroble C, Taylor SL, Taguchi A, Hanash SM, Lebrilla CB, Kim K, Miyamoto S. Enrichment strategies in glycomics based lung cancer biomarker development. Proteomics Clin Appl 7(9-10):664-76, 2013. e-Pub 2013. PMID: 23640812.
185. Taguchi A, Hanash S, Rundle A, McKeague IW, Tang D, Darakjy S, Gaziano JM, Sesso HD, Perera F. Circulating pro-surfactant protein B as a risk biomarker for lung cancer. Cancer Epidemiol Biomarkers Prev 22(10):1756-61, 2013. e-Pub 2013. PMID: 23897585.
186. Hansen JA, Hanash SM, Tabellini L, Baik C, Lawler RL, Grogan BM, Storer B, Chin A, Johnson M, Wong CH, Zhang Q, Martin PJ, McDonald GB. A novel soluble form of Tim-3 associated with Severe Graft-versus-Host Disease. Biol Blood Marrow Transplant 19(9):1323-30, 2013. e-Pub 2013. PMID: 23791624.
187. Vander Lugt MT, Braun TM, Hanash SM, Ritz J, Ho VT, Antin JH, Zhang Q, Wong CH, Wang H, Chin A, Gomez A, Harris AC, Levine JE, Choi SW, Couriel D, Reddy P, Ferrara JL, Paczesny S. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med 369(6):529-39, 2013. e-Pub 2013. PMID: 23924003.
188. Chao T, Ladd JJ, Qiu J, Johnson MM, Israel R, Chin A, Wang H, Prentice RL, Feng Z, Disis ML, Hanash S. Proteomic profiling of the autoimmune response to breast cancer antigens uncovers a suppressive effect of hormone therapy. Proteomics Clin Appl 7(5-6):327-36, 2013. e-Pub 2013. PMID: 23401414.
189. Wu SL, Taylor AD, Lu Q, Hanash SM, Im H, Snyder M, Hancock WS. Identification of potential glycan cancer markers with sialic acid attached to sialic acid and up-regulated fucosylated galactose structures in epidermal growth factor receptor secreted from A431 cell line. Mol Cell Proteomics 12(5):1239-49, 2013. e-Pub 2013. PMID: 23371026.
190. Ladd JJ, Chao T, Johnson MM, Qiu J, Chin A, Israel R, Pitteri SJ, Mao J, Wu M, Amon LM, McIntosh M, Li C, Prentice R, Disis N, Hanash SM. Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among post-menopausal women. Cancer Res 73(5):1502-13, 2013. e-Pub 2013. PMID: 23269276.
191. Liu S, Im H, Bairoch A, Cristofanilli M, Chen R, Deutsch EW, Dalton S, Fenyo D, Fanayan S, Gates C, Gaudet P, Hincapie M, Hanash S, Kim H, Jeong SK, Lundberg E, Mias G, Menon R, Mu Z, Nice E, Paik YK, Uhlen M, Wells L, Wu SL, Yan F, Zhang F, Zhang Y, Snyder M, Omenn GS, Beavis RC, Hancock WS. A Chromosome-centric Human Proteome Project (C-HPP) to Characterize the Sets of Proteins Encoded in Chromosome 17. J Proteome Res 12(1):45-57, 2013. e-Pub 2013. PMID: 23259914.
192. LeBeau AM, Lee M, Murphy ST, Hann BC, Warren RS, Delos Santos R, Kurhanewicz J, Hanash SM, VanBrocklin HF, Craik CS. Imaging a functional tumorigenic biomarker in the transformed epithelium. Proc Natl Acad Sci U S A 110(1):93-8, 2013. e-Pub 2013. PMID: 23248318.
193. Taguchi A, Hanash SM. Unleashing the Power of Proteomics to Develop Blood-Based Cancer Markers. Clin Chem 59(1):119-26, 2013. e-Pub 2013. PMID: 23099557.
194. Baird BN, Schliekelman MJ, Ahn YH, Chen Y, Roybal JD, Gill BJ, Mishra DK, Erez B, O'Reilly M, Yang Y, Patel M, Liu X, Thilaganathan N, Larina IV, Dickinson ME, West JL, Gibbons DL, Liu DD, Kim MP, Hicks JM, Wistuba II, Hanash SM, Kurie JM. Fibulin-2 is a driver of malignant progression in lung adenocarcinoma. PLoS One 8(6):e67054, 2013. e-Pub 2013. PMID: 23785517.
195. Zhang S, Mercado-Uribe I, Hanash SM, Liu J. iTRAQ-Based Proteomic Analysis of Polyploid Giant Cancer Cells and Budding Progeny Cells Reveals Several Distinct Pathways for Ovarian Cancer Development. PLoS One 8(11):e80120, 2013. e-Pub 2013. PMID: 24348907.
196. Thome CH, Dos Santos GA, Ferreira GA, Scheucher PS, Izumi C, Leopoldino AM, Simão AM, Ciancaglini P, de Oliveira KT, Chin A, Hanash SM, Falcão RP, Rego EM, Greene LJ, Faça VM. Linker for Activation of T-cell Family Member2 (LAT2) a Lipid Raft Adaptor Protein for AKT Signaling, Is an Early Mediator of Alkylphospholipid Anti-leukemic Activity. Mol Cell Proteomics 11(12):1898-912, 2012. e-Pub 2012. PMID: 23001822.
197. Hanash SM. A call for a fresh new look at the plasma proteome. Proteomics Clin Appl 6(9-10):443-6, 2012. e-Pub 2012. PMID: 22930569.
198. Li CI, Mirus JE, Zhang Y, Ramirez AB, Ladd JJ, Prentice RL, McIntosh MW, Hanash SM, Lampe PD. Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study. Breast Cancer Res Treat 135(2):611-8, 2012. e-Pub 2012. PMID: 22903690.
199. Lu H, Ladd J, Feng Z, Wu M, Goodell V, Pitteri SJ, Li CI, Prentice R, Hanash SM, Disis ML. Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera. Cancer Prev Res (Phila) 5(8):1036-43, 2012. e-Pub 2012. PMID: 22715141.
200. Hanash SM, Schliekelman M, Zhang Q, Taguchi A. Integration of proteomics into systems biology of cancer. Wiley Interdiscip Rev Syst Biol Med 4(4):327-37, 2012. e-Pub 2012. PMID: 22407608.
201. Kani K, Faca VM, Hughes LD, Zhang W, Fang Q, Shahbaba B, Luethy R, Erde J, Schmidt J, Pitteri SJ, Zhang Q, Katz JE, Gross ME, Plevritis SK, McIntosh MW, Jain A, Hanash SM, Agus DB, Mallick P. Quantitative proteomic profiling identifies protein correlates to EGFR kinase inhibition. Mol Cancer Ther 11(5):1071-81, 2012. e-Pub 2012. PMID: 22411897.
202. Press JZ, Reyes M, Pitteri SJ, Pennil C, Garcia R, Goff BA, Hanash SM, Swisher EM. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration. Int J Gynecol Cancer 22(4):546-52, 2012. e-Pub 2012. PMID: 22315094.
203. Ladd JJ, Busald T, Johnson MM, Zhang Q, Pitteri SJ, Wang H, Brenner DE, Lampe PD, Kucherlapati R, Feng Z, Prentice RL, Hanash SM. Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women. Cancer Prev Res (Phila) 5(4):655-64, 2012. e-Pub 2012. PMID: 22277732.
204. Amon LM, Pitteri SJ, Li CI, McIntosh M, Ladd JJ, Disis M, Porter P, Wong CH, Zhang Q, Lampe P, Prentice RL, Hanash SM. Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer. Cancer Res 72(8):1935-42, 2012. e-Pub 2012. PMID: 22367215.
205. Paik YK, Omenn GS, Uhlen M, Hanash SM, Marko-Varga G, Aebersold R, Bairoch A, Yamamoto T, Legrain P, Lee HJ, Na K, Jeong SK, He F, Binz PA, Nishimura T, Keown P, Baker MS, Yoo JS, Garin J, Archakov A, Bergeron J, Salekdeh GH, Hancock WS. Standard guidelines for the chromosome-centric human proteome project. J Proteome Res 11(4):2005-13, 2012. e-Pub 2012. PMID: 22443261.
206. Paik YK, Jeong SK, Omenn GS, Uhlen M, Hanash SM, Cho SY, Lee HJ, Na K, Choi EY, Yan F, Zhang F, Zhang Y, Snyder M, Cheng Y, Chen R, Marko-Varga G, Deutsch EW, Kim H, Kwon JY, Aebersold R, Bairoch A, Taylor AD, Kim KY, Lee EY, Hochstrasser D, Legrain P, Hancock WS. The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nat Biotechnol 30(3):221-3, 2012. e-Pub 2012. PMID: 22398612.
207. Ferrara JL, Harris AC, Greenson JK, Braun TM, Holler E, Teshima T, Levine JE, Choi SW, Huber E, Landfried K, Akashi K, Vander Lugt M, Reddy P, Chin A, Zhang Q, Hanash SM, Paczesny S. Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood 118(25):6702-8, 2011. e-Pub 2011. PMID: 21979939.
208. Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn YH, Shin DH, Kurie JM, Hanash SM. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res 71(24):7670-82, 2011. e-Pub 2011. PMID: 21987723.
209. Hanash SM, Taguchi A. Application of proteomics to cancer early detection. Clinical Chemistry 17(6):423-8, 2011. e-Pub 2011. PMID: 22157286.
210. Taguchi A, Politi K, Pitteri SJ, Lockwood WW, Faça VM, Kelly-Spratt K, Wong CH, Zhang Q, Chin A, Park KS, Goodman G, Gazdar AF, Sage J, Dinulescu DM, Kucherlapati R, Depinho RA, Kemp CJ, Varmus HE, Hanash SM. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell 20(3):289-99, 2011. e-Pub 2011. PMID: 21907921.
211. Pitteri SJ, Kelly-Spratt KS, Gurley KE, Kennedy J, Buson TB, Chin A, Wang H, Zhang Q, Wong CH, Chodosh LA, Nelson PS, Hanash SM, Kemp CJ. Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression. Cancer Res 71(15):5090-100, 2011. e-Pub 2011. PMID: 21653680.
212. Zeng Z, Hincapie M, Pitteri SJ, Hanash SM, Schalkwijk J, Hogan JM, Wang H, Hancock WS. A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome. Anal Chem 83(12):4845-54, 2011. e-Pub 2011. PMID: 21513341.
213. Hanash SM. Harnessing the immune response for cancer detection. Cancer Epidemiol Biomarkers Prev 20(4):569-70, 2011. e-Pub 2011. PMID: 21454417.
214. Wang H, Wong CH, Chin A, Taguchi A, Taylor A, Hanash SM, Sekiya S, Takahashi H, Murase M, Kajihara S, Iwamoto S, Tanaka K. Integrated mass spectrometry-based analysis of plasma glycoproteins and their glycan modifications. Nat Protoc 6(3):253-69, 2011. e-Pub 2011. PMID: 21372808.
215. Hanash SM. Progress in mining the human proteome for disease applications. OMICS 15(3):133-9, 2011. e-Pub 2011. PMID: 21375461.
216. Pitteri SJ, Hanash SM. Confounding effects of hormone replacement therapy in protein biomarker studies. Cancer Epidemiol Biomarkers Prev 20(1):134-9, 2011. e-Pub 2011. PMID: 21037107.
217. Zhang Q, Taguchi A, Schliekelman M, Wong CH, Chin A, Kuick R, Misek DE, Hanash SM. Comprehensive proteomic profiling of aldehyde dehydrogenases in lung adenocarcinoma cell lines. Int J Proteomics 2011:145010, 2011. e-Pub 2011. PMID: 22110949.
218. Kelly-Spratt KS, Pitteri SJ, Gurley KE, Liggitt D, Chin A, Kennedy J, Wong CH, Zhang Q, Buson TB, Wang H, Hanash SM, Kemp CJ. Plasma proteome profiles associated with inflammation, angiogenesis, and cancer. PLoS One 6(5):e19721, 2011. e-Pub 2011. PMID: 21589862.
219. Hanash SM. Why have protein biomarkers not reached the clinic?. Genome Med 3(10):66, 2011. e-Pub 2011. PMID: 22030259.
220. Wang H, Hanash SM. Intact-protein analysis system for discovery of serum-based disease biomarkers. Methods Mol Biol 728:69-85, 2011. e-Pub 2011. PMID: 21468941.
221. Fang Q, Kani K, Faca VM, Zhang W, Zhang Q, Jain A, Hanash SM, Agus DB, McIntosh MW, Mallick P. Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma. PLoS One 6(7):e23090, 2011. e-Pub 2011. PMID: 21829587.
222. Pitteri SJ, Amon LM, Busald Buson T, Zhang Y, Johnson MM, Chin A, Kennedy J, Wong CH, Zhang Q, Wang H, Lampe PD, Prentice RL, McIntosh MW, Hanash SM, Li CI. Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users. Cancer Res 70(21):8598-606, 2010. e-Pub 2010. PMID: 20959476.
223. Hanash SM, Taguchi A. The grand challenge to decipher the cancer proteome. Nat Rev Cancer 10(9):652-60, 2010. e-Pub 2010. PMID: 20733593.
224. Zeng Z, Hincapie M, Haab BB, Hanash SM, Pitteri SJ, Kluck S, Hogan JM, Kennedy J, Hancock WS. The development of an integrated platform to identify breast cancer glycoproteome changes in human serum. J Chromatogr A 1217(19):3307-15, 2010. e-Pub 2010. PMID: 19782370.
225. Paczesny S, Braun TM, Levine JE, Hogan J, Crawford J, Coffing B, Olsen S, Choi SW, Wang H, Faca V, Pitteri S, Zhang Q, Chin A, Kitko C, Mineishi S, Yanik G, Peres E, Hanauer D, Wang Y, Reddy P, Hanash SM, Ferrara JL. Elafin is a biomarker of graft-versus-host disease of the skin. Sci Transl Med 2(13):13ra2, 2010. e-Pub 2010. PMID: 20371463.
226. Prentice RL, Paczesny S, Aragaki A, Amon LM, Chen L, Pitteri SJ, McIntosh M, Wang P, Buson Busald T, Hsia J, Jackson RD, Rossouw JE, Manson JE, Johnson K, Eaton C, Hanash SM. Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling. Genome Med 2(7):48, 2010. e-Pub 2010. PMID: 20667078.
227. Wang H, Wong CH, Chin A, Kennedy J, Zhang Q, Hanash SM. Quantitative serum proteomics using dual stable isotope coding and nano LC-MS/MSMS. J Proteome Res 8(12):5412-22, 2009. e-Pub 2009. PMID: 19817497.
228. Garcia J, Faca V, Jarzembowski J, Zhang Q, Park J, Hanash SM. Comprehensive profiling of the cell surface proteome of Sy5Y neuroblastoma cells yields a subset of proteins associated with tumor differentiation. J Proteome Res 8(8):3791-6, 2009. e-Pub 2009. PMID: 19505085.
229. Jeong SK, Kwon MS, Lee EY, Lee HJ, Cho SY, Kim H, Yoo JS, Omenn GS, Aebersold R, Hanash SM, Paik YK. BiomarkerDigger: a versatile disease proteome database and analysis platform for the identification of plasma cancer biomarkers. Proteomics 9(14):3729-40, 2009. e-Pub 2009. PMID: 19639590.
230. Diamandis EP, Hanash SM, Lopez M, Carr S, Petricoin EF. Protein quantification by mass spectrometry: is it ready for prime time?. Clin Chem 55(7):1427-30, 2009. e-Pub 2009. PMID: 19443560.
231. Vilar E, Mukherjee B, Kuick R, Raskin L, Misek DE, Taylor JM, Giordano TJ, Hanash SM, Fearon ER, Rennert G, Gruber SB. Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway. Clin Cancer Res 15(8):2829-39, 2009. e-Pub 2009. PMID: 19351759.
232. Vaisocherová H, Faca VM, Taylor AD, Hanash SM, Jiang S. Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera. Biosens Bioelectron 24(7):2143-8, 2009. e-Pub 2009. PMID: 19157844.
233. Fang Q, Strand A, Law W, Faca VM, Fitzgibbon MP, Hamel N, Houle B, Liu X, May DH, Poschmann G, Roy L, Stühler K, Ying W, Zhang J, Zheng Z, Bergeron JJ, Hanash SM, He F, Leavitt BR, Meyer HE, Qian X, McIntosh MW. Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease. Mol Cell Proteomics 8(3):451-66, 2009. e-Pub 2009. PMID: 18984577.
234. Hung KE, Faca V, Song K, Sarracino DA, Richard LG, Krastins B, Forrester S, Porter A, Kunin A, Mahmood U, Haab BB, Hanash SM, Kucherlapati R. Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis. Cancer Prev Res (Phila) 2(3):224-33, 2009. e-Pub 2009. PMID: 19240248.
235. Liu Y, Kuick R, Hanash SM, Richardson B. DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin Immunol 130(2):213-24, 2009. e-Pub 2009. PMID: 18945643.
236. Souchelnytskyi S, Hanash SM. Focus on breast cancer proteomics. Proteomics Clin Appl 3(1):5, 2009. e-Pub 2009. PMID: 21136931.
237. Paczesny S, Krijanovski OI, Braun TM, Choi SW, Clouthier SG, Kuick R, Misek DE, Cooke KR, Kitko CL, Weyand A, Bickley D, Jones D, Whitfield J, Reddy P, Levine JE, Hanash SM, Ferrara JL. A biomarker panel for acute graft-versus-host disease. Blood 113(2):273-8, 2009. e-Pub 2009. PMID: 18832652.
238. Menon R, Zhang Q, Zhang Y, Fermin D, Bardeesy N, DePinho RA, Lu C, Hanash SM, Omenn GS, States DJ. Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer. Cancer Res 69(1):300-9, 2009. e-Pub 2009. PMID: 19118015.
239. Faca V, Wang H, Hanash SM. Proteomic global profiling for cancer biomarker discovery. Methods Mol Biol 492:309-20, 2009. e-Pub 2009. PMID: 19241042.
240. Taylor AD, Hancock WS, Hincapie M, Taniguchi N, Hanash SM. Towards an integrated proteomic and glycomic approach to finding cancer biomarkers. Genome Med 1(6):57, 2009. e-Pub 2009. PMID: 19519948.
241. Katayama H, Paczesny S, Prentice R, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J, Rossouw J, Jackson R, Hsia J, Chlebowski R, Manson J, Hanash SM. Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings. Genome Med 1(4):47, 2009. e-Pub 2009. PMID: 19402886.
242. Pitteri SJ, JeBailey L, Faça VM, Thorpe JD, Silva MA, Ireton RC, Horton MB, Wang H, Pruitt LC, Zhang Q, Cheng KH, Urban N, Hanash SM, Dinulescu DM. Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS One 4(11):e7916, 2009. e-Pub 2009. PMID: 19936259.
243. Wang H, Hanash SM. Electrospray mass spectrometry for quantitative plasma proteome analysis. Methods Mol Biol 564:227-42, 2009. e-Pub 2009. PMID: 19544026.
244. Pitteri SJ, Hanash SM, Aragaki A, Amon LM, Chen L, Busald Buson T, Paczesny S, Katayama H, Wang H, Johnson MM, Zhang Q, McIntosh M, Wang P, Kooperberg C, Rossouw JE, Jackson RD, Manson JE, Hsia J, Liu S, Martin L, Prentice RL. Postmenopausal estrogen and progestin effects on the serum proteome. Genome Med 1(12):121, 2009. e-Pub 2009. PMID: 20034393.
245. May D, Liu Y, Law W, Fitzgibbon M, Wang H, Hanash SM, McIntosh M. Peptide sequence confidence in accurate mass and time analysis and its use in complex proteomics experiments. J Proteome Res 7(12):5148-56, 2008. e-Pub 2008. PMID: 19367719.
246. McIntosh M, Anderson G, Drescher C, Hanash SM, Urban N, Brown P, Gambhir SS, Coukos G, Laird PW, Nelson B, Palmer C. Ovarian cancer early detection claims are biased. Clin Cancer Res 14(22):7574; author reply 7577-9, 2008. e-Pub 2008. PMID: 18948385.
247. Creighton CJ, Nagaraja AK, Hanash SM, Matzuk MM, Gunaratne PH. A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions. RNA 14(11):2290-6, 2008. e-Pub 2008. PMID: 18812437.
248. Qiu J, Choi G, Li L, Wang H, Pitteri SJ, Pereira-Faca SR, Krasnoselsky AL, Randolph TW, Omenn GS, Edelstein C, Barnett MJ, Thornquist MD, Goodman GE, Brenner DE, Feng Z, Hanash SM. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. J Clin Oncol 26(31):5060-6, 2008. e-Pub 2008. PMID: 18794547.
249. Luethy R, Kessner DE, Katz JE, Maclean B, Grothe R, Kani K, Faça V, Pitteri S, Hanash SM, Agus DB, Mallick P. Precursor-ion mass re-estimation improves peptide identification on hybrid instruments. J Proteome Res 7(9):4031-9, 2008. e-Pub 2008. PMID: 18707148.
250. Kim YS, Son OL, Lee JY, Kim SH, Oh S, Lee YS, Kim CH, Yoo JS, Lee JH, Miyoshi E, Taniguchi N, Hanash SM, Yoo HS, Ko JH. Lectin precipitation using phytohemagglutinin-L(4) coupled to avidin-agarose for serological biomarker discovery in colorectal cancer. Proteomics 8(16):3229-35, 2008. e-Pub 2008. PMID: 18633972.
251. Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giordano TJ, Misek DE, Chang AC, Zhu CQ, Strumpf D, Hanash SM, Shepherd FA, Ding K, Seymour L, Naoki K, Pennell N, Weir B, Verhaak R, Ladd-Acosta C, Golub T, Gruidl M, Sharma A, Szoke J, Zakowski M, Rusch V, Kris M, Viale A, Motoi N, Travis W, Conley B, Seshan VE, Meyerson M, Kuick R, Dobbin KK, Lively T, Jacobson JW, Beer DG. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma Nature Medicine 14(8):822-7, 2008. e-Pub 2008. PMID: 18641660.
252. Wang H, Hanash SM. Increased throughput and reduced carryover of mass spectrometry-based proteomics using a high-efficiency nonsplit nanoflow parallel dual-column capillary HPLC system. J Proteome Res 7(7):2743-55, 2008. e-Pub 2008. PMID: 18512973.
253. Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ, Pereira-Faca SR, Ireton RC, Katayama H, Glukhova V, Phanstiel D, Brenner DE, Anderson MA, Misek D, Scholler N, Urban ND, Barnett MJ, Edelstein C, Goodman GE, Thornquist MD, McIntosh MW, DePinho RA, Bardeesy N, Hanash SM. A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med 5(6):e123, 2008. e-Pub 2008. PMID: 18547137.
254. Krasnoselsky AL, Faca VM, Pitteri SJ, Zhang Q, Hanash SM. Isoform analysis of LC-MS/MS data from multidimensional fractionation of the serum proteome. J Proteome Res 7(6):2546-52, 2008. e-Pub 2008. PMID: 18419151.
255. Pitteri SJ, Faca VM, Kelly-Spratt KS, Kasarda AE, Wang H, Zhang Q, Newcomb L, Krasnoselsky A, Paczesny S, Choi G, Fitzgibbon M, McIntosh MW, Kemp CJ, Hanash SM. Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells. J Proteome Res 7(4):1481-9, 2008. e-Pub 2008. PMID: 18311905.
256. Madoz-Gúrpide J, Kuick R, Wang H, Misek DE, Hanash SM. Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Mol Cell Proteomics 7(2):268-81, 2008. e-Pub 2008. PMID: 17916591.
257. Mathivanan S, Ahmed M, Ahn NG, Alexandre H, Amanchy R, Andrews PC, Bader JS, Balgley BM, Bantscheff M, Bennett KL, Björling E, Blagoev B, Bose R, Brahmachari SK, Burlingame AS, Bustelo XR, Cagney G, Cantin GT, Cardasis HL, Celis JE, Chaerkady R, Chu F, Cole PA, Costello CE, Cotter RJ, Crockett D, DeLany JP, De Marzo AM, DeSouza LV, Deutsch EW, Dransfield E, Drewes G, Droit A, Dunn MJ, Elenitoba-Johnson K, Ewing RM, Van Eyk J, Faca V, Falkner J, Fang X, Fenselau C, Figeys D, Gagné P, Gelfi C, Gevaert K, Gimble JM, Gnad F, Goel R, Gromov P, Hanash SM, Hancock WS, Harsha HC, Hart G, Hays F, He F, Hebbar P, Helsens K, Hermeking H, Hide W, Hjernø K, Hochstrasser DF, Hofmann O, Horn DM, Hruban RH, Ibarrola N, James P, Jensen ON, Jensen PH, Jung P, Kandasamy K, Kheterpal I, Kikuno RF, Korf U, Körner R, Kuster B, Kwon MS, Lee HJ, Lee YJ, Lefevre M, Lehvaslaiho M, Lescuyer P, Levander F, Lim MS, Löbke C, Loo JA, Mann M, Martens L, Martinez-Heredia J, McComb M, McRedmond J, Mehrle A, Menon R, Miller CA, Mischak H, Mohan SS, Mohmood R, Molina H, Moran MF, Morgan JD, Moritz R, Morzel M, Muddiman DC, Nalli A, Navarro JD, Neubert TA, Ohara O, Oliva R, Omenn GS, Oyama M, Paik YK, Pennington K, Pepperkok R, Periaswamy B, Petricoin EF, Poirier GG, Prasad TS, Purvine SO, Rahiman BA, Ramachandran P, Ramachandra YL, Rice RH, Rick J, Ronnholm RH, Salonen J, Sanchez JC, Sayd T, Seshi B, Shankari K, Sheng SJ, Shetty V, Shivakumar K, Simpson RJ, Sirdeshmukh R, Siu KW, Smith JC, Smith RD, States DJ, Sugano S, Sullivan M, Superti-Furga G, Takatalo M, Thongboonkerd V, Trinidad JC, Uhlen M, Vandekerckhove J, Vasilescu J, Veenstra TD, Vidal-Taboada JM, Vihinen M, Wait R, Wang X, Wiemann S, Wu B, Xu T, Yates JR, Zhong J, Zhou M, Zhu Y, Zurbig P, Pandey A. Human Proteinpedia enables sharing of human protein data. Nat Biotechnol 26(2):164-7, 2008. e-Pub 2008. PMID: 18259167.
258. Faça VM, Ventura AP, Fitzgibbon MP, Pereira-Faça SR, Pitteri SJ, Green AE, Ireton RC, Zhang Q, Wang H, O'Briant KC, Drescher CW, Schummer M, McIntosh MW, Knudsen BS, Hanash SM. Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains. PLoS One 3(6):e2425, 2008. e-Pub 2008. PMID: 18560578.
259. Zhang Q, Menon R, Deutsch EW, Pitteri SJ, Faca VM, Wang H, Newcomb LF, Depinho RA, Bardeesy N, Dinulescu D, Hung KE, Kucherlapati R, Jacks T, Politi K, Aebersold R, Omenn GS, States DJ, Hanash SM. A mouse plasma peptide atlas as a resource for disease proteomics. Genome Biol 9(6):R93, 2008. e-Pub 2008. PMID: 18522751.
260. Pereira-Faca SR, Kuick R, Puravs E, Zhang Q, Krasnoselsky AL, Phanstiel D, Qiu J, Misek DE, Hinderer R, Tammemagi M, Landi MT, Caporaso N, Pfeiffer R, Edelstein C, Goodman G, Barnett M, Thornquist M, Brenner D, Hanash SM. Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer. Cancer Res 67(24):12000-6, 2007. e-Pub 2007. PMID: 18089831.
261. Pitteri SJ, Hanash SM. Proteomic approaches for cancer biomarker discovery in plasma. Expert Rev Proteomics 4(5):589-90, 2007. e-Pub 2007. PMID: 17941811.
262. Faca V, Pitteri SJ, Newcomb L, Glukhova V, Phanstiel D, Krasnoselsky A, Zhang Q, Struthers J, Wang H, Eng J, Fitzgibbon M, McIntosh M, Hanash SM. Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J Proteome Res 6(9):3558-65, 2007. e-Pub 2007. PMID: 17696519.
263. Hanash SM. It takes a village to develop biomarkers. J Proteome Res 6(9):3362, 2007. e-Pub 2007. PMID: 17924484.
264. Faca V, Hanash SM. In-depth quantitative proteomics for pancreatic cancer biomarker discovery. Expert Opin Med Diagn 1(1):81-9, 2007. e-Pub 2007. PMID: 23489270.
265. Forrester S, Qiu J, Mangold L, Partin A, Misek D, Phinney B, Whitten D, Andrews P, Diamandis E, Omenn GS, Hanash SM, Haab BB. An experimental strategy for quantitative analysis of the humoral immune response to prostate cancer antigens using natural protein microarrays. Proteomics Clin Appl 1(5):494-505, 2007. e-Pub 2007. PMID: 21136701.
266. Wu R, Hendrix-Lucas N, Kuick R, Zhai Y, Schwartz DR, Akyol A, Hanash SM, Misek DE, Katabuchi H, Williams BO, Fearon ER, Cho KR. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. Cancer Cell 11(4):321-33, 2007. e-Pub 2007. PMID: 17418409.
267. Seliger B, Fedorushchenko A, Brenner W, Ackermann A, Atkins D, Hanash SM, Lichtenfels R. Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration. Clin Cancer Res 13(1):27-37, 2007. e-Pub 2007. PMID: 17200335.
268. Mannová P, Fang R, Wang H, Deng B, McIntosh MW, Hanash SM, Beretta L. Modification of host lipid raft proteome upon hepatitis C virus replication. Mol Cell Proteomics 5(12):2319-25, 2006. e-Pub 2006. PMID: 16943187.
269. Song K, Hanash SM. Unraveling the complex proteome for biomarker discovery in gastrointestinal and liver diseases. Gastroenterology 131(5):1375-8, 2006. e-Pub 2006. PMID: 17064703.
270. Djuric U, El-Maarri O, Lamb B, Kuick R, Seoud M, Coullin P, Oldenburg J, Hanash SM, Slim R. Familial molar tissues due to mutations in the inflammatory gene, NALP7, have normal postzygotic DNA methylation. Hum Genet 120(3):390-5, 2006. e-Pub 2006. PMID: 16874523.
271. Gupta A, Williams BR, Hanash SM, Rawwas J. Cellular retinoic acid-binding protein II is a direct transcriptional target of MycN in neuroblastoma. Cancer Res 66(16):8100-8, 2006. e-Pub 2006. PMID: 16912187.
272. Faca V, Coram M, Phanstiel D, Glukhova V, Zhang Q, Fitzgibbon M, McIntosh M, Hanash SM. Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS. J Proteome Res 5(8):2009-18, 2006. e-Pub 2006. PMID: 16889424.
273. Kubisch CH, Gukovsky I, Lugea A, Pandol SJ, Kuick R, Misek DE, Hanash SM, Logsdon CD. Long-term ethanol consumption alters pancreatic gene expression in rats: a possible connection to pancreatic injury. Pancreas 33(1):68-76, 2006. e-Pub 2006. PMID: 16804415.
274. Chignard N, Shang S, Wang H, Marrero J, Bréchot C, Hanash SM, Beretta L. Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera. Gastroenterology 130(7):2010-22, 2006. e-Pub 2006. PMID: 16762624.
275. Giordano TJ, Au AY, Kuick R, Thomas DG, Rhodes DR, Wilhelm KG, Vinco M, Misek DE, Sanders D, Zhu Z, Ciampi R, Hanash SM, Chinnaiyan A, Clifton-Bligh RJ, Robinson BG, Nikiforov YE, Koenig RJ. Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation. Clin Cancer Res 12(7 Pt 1):1983-93, 2006. e-Pub 2006. PMID: 16609007.
276. States DJ, Omenn GS, Blackwell TW, Fermin D, Eng J, Speicher DW, Hanash SM. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat Biotechnol 24(3):333-8, 2006. e-Pub 2006. PMID: 16525410.
277. Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, Bagga R, Kircheisen R, Ao A, Ratti B, Hanash SM, Rouleau GA, Slim R. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet 38(3):300-2, 2006. e-Pub 2006. PMID: 16462743.
278. Rauch A, Bellew M, Eng J, Fitzgibbon M, Holzman T, Hussey P, Igra M, Maclean B, Lin CW, Detter A, Fang R, Faca V, Gafken P, Zhang H, Whiteaker J, Whitaker J, States D, Hanash SM, Paulovich A, McIntosh MW. Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. J Proteome Res 5(1):112-21, 2006. e-Pub 2006. PMID: 16396501.
279. Hong SH, Misek DE, Wang H, Puravs E, Hinderer R, Giordano TJ, Greenson JK, Brenner DE, Simeone DM, Logsdon CD, Hanash SM. Identification of a Specific Vimentin Isoform That Induces an Antibody Response in Pancreatic Cancer. Biomark Insights 1:175-183, 2006. e-Pub 2006. PMID: 18769604.
280. Giordano TJ, Kuick R, Thomas DG, Misek DE, Vinco M, Sanders D, Zhu Z, Ciampi R, Roh M, Shedden K, Gauger P, Doherty G, Thompson NW, Hanash SM, Koenig RJ, Nikiforov YE. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene 24(44):6646-56, 2005. e-Pub 2005. PMID: 16007166.
281. Ping P, Vondriska TM, Creighton CJ, Gandhi TK, Yang Z, Menon R, Kwon MS, Cho SY, Drwal G, Kellmann M, Peri S, Suresh S, Gronborg M, Molina H, Chaerkady R, Rekha B, Shet AS, Gerszten RE, Wu H, Raftery M, Wasinger V, Schulz-Knappe P, Hanash SM, Paik YK, Hancock WS, States DJ, Omenn GS, Pandey A. A functional annotation of subproteomes in human plasma. Proteomics 5(13):3506-19, 2005. e-Pub 2005. PMID: 16104058.
282. Misek DE, Kuick R, Wang H, Galchev V, Deng B, Zhao R, Tra J, Pisano MR, Amunugama R, Allen D, Walker AK, Strahler JR, Andrews P, Omenn GS, Hanash SM. A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system. Proteomics 5(13):3343-52, 2005. e-Pub 2005. PMID: 16047307.
283. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, Apweiler R, Haab BB, Simpson RJ, Eddes JS, Kapp EA, Moritz RL, Chan DW, Rai AJ, Admon A, Aebersold R, Eng J, Hancock WS, Hefta SA, Meyer H, Paik YK, Yoo JS, Ping P, Pounds J, Adkins J, Qian X, Wang R, Wasinger V, Wu CY, Zhao X, Zeng R, Archakov A, Tsugita A, Beer I, Pandey A, Pisano M, Andrews P, Tammen H, Speicher DW, Hanash SM. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5(13):3226-45, 2005. e-Pub 2005. PMID: 16104056.
284. Rozek LS, Lipkin SM, Fearon ER, Hanash SM, Giordano TJ, Greenson JK, Kuick R, Misek DE, Taylor JM, Douglas JA, Rennert G, Gruber SB. CDX2 polymorphisms, RNA expression, and risk of colorectal cancer. Cancer Res 65(13):5488-92, 2005. e-Pub 2005. PMID: 15994917.
285. Li JY, Kuick R, Thompson RC, Misek DE, Lai YM, Liu YQ, Chai BX, Hanash SM, Gantz I. Arcuate nucleus transcriptome profiling identifies ankyrin repeat and suppressor of cytokine signalling box-containing protein 4 as a gene regulated by fasting in central nervous system feeding circuits. J Neuroendocrinol 17(6):394-404, 2005. e-Pub 2005. PMID: 15929745.
286. Wang H, Clouthier SG, Galchev V, Misek DE, Duffner U, Min CK, Zhao R, Tra J, Omenn GS, Ferrara JL, Hanash SM. Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids. Mol Cell Proteomics 4(5):618-25, 2005. e-Pub 2005. PMID: 15703445.
287. Hinoi T, Gesina G, Akyol A, Kuick R, Hanash SM, Giordano TJ, Gruber SB, Fearon ER. CDX2-regulated expression of iron transport protein hephaestin in intestinal and colonic epithelium. Gastroenterology 128(4):946-61, 2005. e-Pub 2005. PMID: 15825077.
288. Creighton CJ, Bromberg-White JL, Misek DE, Monsma DJ, Brichory F, Kuick R, Giordano TJ, Gao W, Omenn GS, Webb CP, Hanash SM. Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation. Mol Cancer Res 3(3):119-29, 2005. e-Pub 2005. PMID: 15798092.
289. Nam MJ, Kee MK, Kuick R, Hanash SM. Identification of defensin alpha6 as a potential biomarker in colon adenocarcinoma. J Biol Chem 280(9):8260-5, 2005. e-Pub 2005. PMID: 15613481.
290. Williams TM, Williams ME, Kuick R, Misek D, McDonagh K, Hanash SM, Innis JW. Candidate downstream regulated genes of HOX group 13 transcription factors with and without monomeric DNA binding capability. Dev Biol 279(2):462-80, 2005. e-Pub 2005. PMID: 15733672.
291. Shedden KA, Kshirsagar MP, Schwartz DR, Wu R, Yu H, Misek DE, Hanash SM, Katabuchi H, Ellenson LH, Fearon ER, Cho KR. Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas. Clin Cancer Res 11(6):2123-31, 2005. e-Pub 2005. PMID: 15788657.
292. Dobbin KK, Beer DG, Meyerson M, Yeatman TJ, Gerald WL, Jacobson JW, Conley B, Buetow KH, Heiskanen M, Simon RM, Minna JD, Girard L, Misek DE, Taylor JM, Hanash SM, Naoki K, Hayes DN, Ladd-Acosta C, Enkemann SA, Viale A, Giordano TJ. Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin Cancer Res 11(2 Pt 1):565-72, 2005. e-Pub 2005. PMID: 15701842.
293. Misek DE, Kuick R, Hanash SM, Logsdon CD. Oligonucleotide-directed microarray gene profiling of pancreatic adenocarcinoma. Methods Mol Med 103:175-87, 2005. e-Pub 2005. PMID: 15542906.
294. Gao WM, Kuick R, Orchekowski RP, Misek DE, Qiu J, Greenberg AK, Rom WN, Brenner DE, Omenn GS, Haab BB, Hanash SM. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer 5:110, 2005. e-Pub 2005. PMID: 16117833.
295. Shedden K, Chen W, Kuick R, Ghosh D, Macdonald J, Cho KR, Giordano TJ, Gruber SB, Fearon ER, Taylor JM, Hanash SM. Comparison of seven methods for producing Affymetrix expression scores based on False Discovery Rates in disease profiling data. BMC Bioinformatics 6:26, 2005. e-Pub 2005. PMID: 15705192.
296. Marcus B, Arenberg D, Lee J, Kleer C, Chepeha DB, Schmalbach CE, Islam M, Paul S, Pan Q, Hanash SM, Kuick R, Merajver SD, Teknos TN. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 101(12):2779-87, 2004. e-Pub 2004. PMID: 15546137.
297. Binkley CE, Zhang L, Greenson JK, Giordano TJ, Kuick R, Misek D, Hanash SM, Logsdon CD, Simeone DM. The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma. Pancreas 29(4):254-63, 2004. e-Pub 2004. PMID: 15502640.
298. Barnes BJ, Richards J, Mancl M, Hanash SM, Beretta L, Pitha PM. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem 279(43):45194-207, 2004. e-Pub 2004. PMID: 15308637.
299. Girard S, Vossman E, Misek DE, Podevin P, Hanash SM, Bréchot C, Beretta L. Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses. Hepatology 40(3):708-18, 2004. e-Pub 2004. PMID: 15349911.
300. Engstrom LD, Youkilis AS, Gorelick JL, Zheng D, Ackley V, Petroff CA, Benson LQ, Coon MR, Zhu X, Hanash SM, Wechsler DS. Mxi1-0, an alternatively transcribed Mxi1 isoform, is overexpressed in glioblastomas. Neoplasia 6(5):660-73, 2004. e-Pub 2004. PMID: 15548375.
301. Hong SH, Misek DE, Wang H, Puravs E, Giordano TJ, Greenson JK, Brenner DE, Simeone DM, Logsdon CD, Hanash SM. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer. Cancer Res 64(15):5504-10, 2004. e-Pub 2004. PMID: 15289361.
302. Cuezva JM, Chen G, Alonso AM, Isidoro A, Misek DE, Hanash SM, Beer DG. The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis 25(7):1157-63, 2004. e-Pub 2004. PMID: 14963017.
303. Oelke K, Lu Q, Richardson D, Wu A, Deng C, Hanash SM, Richardson B. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum 50(6):1850-60, 2004. e-Pub 2004. PMID: 15188362.
304. Zatkova A, Ullmann R, Rouillard JM, Lamb BJ, Kuick R, Hanash SM, Schnittger S, Schoch C, Fonatsch C, Wimmer K. Distinct sequences on 11q13.5 and 11q23-24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patients. Genes Chromosomes Cancer 39(4):263-76, 2004. e-Pub 2004. PMID: 14978788.
305. Asakawa J, Kuick R, Kodaira M, Nakamura N, Katayama H, Pierce D, Funamoto S, Preston D, Satoh C, Neel JV, Hanash SM. A genome scanning approach to assess the genetic effects of radiation in mice and humans. Radiat Res 161(4):380-90, 2004. e-Pub 2004. PMID: 15038760.
306. Gharib TG, Chen G, Huang CC, Misek DE, Iannettoni MD, Hanash SM, Orringer MB, Beer DG. Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas. Clin Lung Cancer 5(5):307-12, 2004. e-Pub 2004. PMID: 15086970.
307. Chen G, Wang H, Miller CT, Thomas DG, Gharib TG, Misek DE, Giordano TJ, Orringer MB, Hanash SM, Beer DG. Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J Pathol 202(3):321-9, 2004. e-Pub 2004. PMID: 14991897.
308. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, Wolf GT, Kuick R, Misek DE, Trask DK, Hanash SM. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130(3):295-302, 2004. e-Pub 2004. PMID: 15023835.
309. Toraason M, Albertini R, Bayard S, Bigbee W, Blair A, Boffetta P, Bonassi S, Chanock S, Christiani D, Eastmond D, Hanash SM, Henry C, Kadlubar F, Mirer F, Nebert D, Rapport S, Rest K, Rothman N, Ruder A, Savage R, Schulte P, Siemiatycki J, Shields P, Smith M, Tolbert P, Vermeulen R, Vineis P, Wacholder S, Ward E, Waters M, Weston A. Applying new biotechnologies to the study of occupational cancer--a workshop summary. Environ Health Perspect 112(4):413-6, 2004. e-Pub 2004. PMID: 15033588.
310. Zatkova A, Rouillard JM, Hartmann W, Lamb BJ, Kuick R, Eckart M, von Schweinitz D, Koch A, Fonatsch C, Pietsch T, Hanash SM, Wimmer K. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma. Genes Chromosomes Cancer 39(2):126-37, 2004. e-Pub 2004. PMID: 14695992.
311. Bouwman K, Qiu J, Zhou H, Schotanus M, Mangold LA, Vogt R, Erlandson E, Trenkle J, Partin AW, Misek D, Omenn GS, Haab BB, Hanash SM. Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity. Proteomics 3(11):2200-7, 2003. e-Pub 2003. PMID: 14595819.
312. Shedden KA, Taylor JM, Giordano TJ, Kuick R, Misek DE, Rennert G, Schwartz DR, Gruber SB, Logsdon C, Simeone D, Kardia SL, Greenson JK, Cho KR, Beer DG, Fearon ER, Hanash SM. Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework. Am J Pathol 163(5):1985-95, 2003. e-Pub 2003. PMID: 14578198.
313. Nam MJ, Madoz-Gurpide J, Wang H, Lescure P, Schmalbach CE, Zhao R, Misek DE, Kuick R, Brenner DE, Hanash SM. Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics 3(11):2108-15, 2003. e-Pub 2003. PMID: 14595809.
314. Chen J, Mo R, Lescure PA, Misek DE, Hanash SM, Rochford R, Hobbs M, Yung RL. Aging is associated with increased T-cell chemokine expression in C57BL/6 mice. J Gerontol A Biol Sci Med Sci 58(11):975-83, 2003. e-Pub 2003. PMID: 14630877.
315. Chen G, Gharib TG, Wang H, Huang CC, Kuick R, Thomas DG, Shedden KA, Misek DE, Taylor JM, Giordano TJ, Kardia SL, Iannettoni MD, Yee J, Hogg PJ, Orringer MB, Hanash SM, Beer DG. Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci U S A 100(23):13537-42, 2003. e-Pub 2003. PMID: 14573703.
316. Hanash SM. The emerging field of protein microarrays. Proteomics 3(11):2075, 2003. e-Pub 2003. PMID: 14595827.
317. Jang JH, Hanash SM. Profiling of the cell surface proteome. Proteomics 3(10):1947-54, 2003. e-Pub 2003. PMID: 14625857.
318. van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS, Sommer C, Reifenberger G, Hanash SM. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 163(3):1033-43, 2003. e-Pub 2003. PMID: 12937144.
319. Miller CT, Chen G, Gharib TG, Wang H, Thomas DG, Misek DE, Giordano TJ, Yee J, Orringer MB, Hanash SM, Beer DG. Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas. Oncogene 22(39):7950-7, 2003. e-Pub 2003. PMID: 12970743.
320. Grolleau A, Misek DE, Kuick R, Hanash SM, Mulé JJ. Inducible expression of macrophage receptor Marco by dendritic cells following phagocytic uptake of dead cells uncovered by oligonucleotide arrays. J Immunol 171(6):2879-88, 2003. e-Pub 2003. PMID: 12960310.
321. Ichiba T, Teshima T, Kuick R, Misek DE, Liu C, Takada Y, Maeda Y, Reddy P, Williams DL, Hanash SM, Ferrara JL. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood 102(2):763-71, 2003. e-Pub 2003. PMID: 12663442.
322. Schwartz DR, Wu R, Kardia SL, Levin AM, Huang CC, Shedden KA, Kuick R, Misek DE, Hanash SM, Taylor JM, Reed H, Hendrix N, Zhai Y, Fearon ER, Cho KR. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. Cancer Res 63(11):2913-22, 2003. e-Pub 2003. PMID: 12782598.
323. Ji B, Chen XQ, Misek DE, Kuick R, Hanash SM, Ernst S, Najarian R, Logsdon CD. Pancreatic gene expression during the initiation of acute pancreatitis: identification of EGR-1 as a key regulator. Physiol Genomics 14(1):59-72, 2003. e-Pub 2003. PMID: 12709512.
324. Wu R, Lin L, Beer DG, Ellenson LH, Lamb BJ, Rouillard JM, Kuick R, Hanash SM, Schwartz DR, Fearon ER, Cho KR. Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas. Am J Pathol 162(5):1603-10, 2003. e-Pub 2003. PMID: 12707044.
325. Lu Q, Wu A, Ray D, Deng C, Attwood J, Hanash SM, Pipkin M, Lichtenheld M, Richardson B. DNA methylation and chromatin structure regulate T cell perforin gene expression. J Immunol 170(10):5124-32, 2003. e-Pub 2003. PMID: 12734359.
326. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE, Kuick R, Hanash SM. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63(10):2649-57, 2003. e-Pub 2003. PMID: 12750293.
327. Creighton C, Hanash SM, Beer D. Gene expression patterns define pathways correlated with loss of differentiation in lung adenocarcinomas. FEBS Lett 540(1-3):167-70, 2003. e-Pub 2003. PMID: 12681502.
328. Chen G, Gharib TG, Thomas DG, Huang CC, Misek DE, Kuick RD, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Proteomic analysis of eIF-5A in lung adenocarcinomas. Proteomics 3(4):496-504, 2003. e-Pub 2003. PMID: 12687616.
329. Chen G, Wang H, Gharib TG, Huang CC, Thomas DG, Shedden KA, Kuick R, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell Proteomics 2(2):107-16, 2003. e-Pub 2003. PMID: 12644570.
330. Shin BK, Wang H, Yim AM, Le Naour F, Brichory F, Jang JH, Zhao R, Puravs E, Tra J, Michael CW, Misek DE, Hanash SM. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem 278(9):7607-16, 2003. e-Pub 2003. PMID: 12493773.
331. Giordano TJ, Thomas DG, Kuick R, Lizyness M, Misek DE, Smith AL, Sanders D, Aljundi RT, Gauger PG, Thompson NW, Taylor JM, Hanash SM. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am J Pathol 162(2):521-31, 2003. e-Pub 2003. PMID: 12547710.
332. Creighton C, Hanash SM. Mining gene expression databases for association rules. Bioinformatics 19(1):79-86, 2003. e-Pub 2003. PMID: 12499296.
333. Mo R, Chen J, Han Y, Bueno-Cannizares C, Misek DE, Lescure PA, Hanash SM, Yung RL. T cell chemokine receptor expression in aging. J Immunol 170(2):895-904, 2003. e-Pub 2003. PMID: 12517955.
334. Hanash SM. Harnessing immunity for cancer marker discovery. Nat Biotechnol 21(1):37-8, 2003. e-Pub 2003. PMID: 12511908.
335. Hanash SM, Creighton C. Making sense of microarray data to classify cancer. Pharmacogenomics J 3(6):308-11, 2003. e-Pub 2003. PMID: 14597962.
336. Creighton C, Kuick R, Misek DE, Rickman DS, Brichory FM, Rouillard JM, Omenn GS, Hanash SM. Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice. Genome Biol 4(7):R46, 2003. e-Pub 2003. PMID: 12844362.
337. Creighton C, Hanash SM. Expression of matrix metalloproteinase 9 (MMP-9/gelatinase B) in adenocarcinomas strongly correlated with expression of immune response genes. In Silico Biol 3(3):301-11, 2003. e-Pub 2003. PMID: 12954092.
338. Moran CJ, Arenberg DA, Huang CC, Giordano TJ, Thomas DG, Misek DE, Chen G, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. RANTES expression is a predictor of survival in stage I lung adenocarcinoma. Clin Cancer Res 8(12):3803-12, 2002. e-Pub 2002. PMID: 12473593.
339. Hinoi T, Lucas PC, Kuick R, Hanash SM, Cho KR, Fearon ER. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 123(5):1565-77, 2002. e-Pub 2002. PMID: 12404231.
340. Zhu X, Wimmer K, Kuick R, Lamb BJ, Motyka S, Jasty R, Castle VP, Hanash SM. N-myc modulates expression of p73 in neuroblastoma. Neoplasia 4(5):432-9, 2002. e-Pub 2002. PMID: 12192602.
341. Gharib TG, Chen G, Wang H, Huang CC, Prescott MS, Shedden K, Misek DE, Thomas DG, Giordano TJ, Taylor JM, Kardia S, Yee J, Orringer MB, Hanash SM, Beer DG. Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia 4(5):440-8, 2002. e-Pub 2002. PMID: 12192603.
342. Misek DE, Chang CL, Kuick R, Hinderer R, Giordano TJ, Beer DG, Hanash SM. Transforming properties of a Q18-->E mutation of the microtubule regulator Op18. Cancer Cell 2(3):217-28, 2002. e-Pub 2002. PMID: 12242154.
343. Lin L, Miller CT, Contreras JI, Prescott MS, Dagenais SL, Wu R, Yee J, Orringer MB, Misek DE, Hanash SM, Glover TW, Beer DG. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res 62(18):5273-9, 2002. e-Pub 2002. PMID: 12234996.
344. Tra J, Kondo T, Lu Q, Kuick R, Hanash SM, Richardson B. Infrequent occurrence of age-dependent changes in CpG island methylation as detected by restriction landmark genome scanning. Mech Ageing Dev 123(11):1487-503, 2002. e-Pub 2002. PMID: 12425956.
345. Hanash SM. Samir Hanash discusses how HUPO aims to globalize proteomics research (interview by Joanna Owens). Drug Discov Today 7(15):797-801, 2002. e-Pub 2002. PMID: 12546963.
346. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB, Hanash SM. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8(8):816-24, 2002. e-Pub 2002. PMID: 12118244.
347. Ross SE, Erickson RL, Gerin I, DeRose PM, Bajnok L, Longo KA, Misek DE, Kuick R, Hanash SM, Atkins KB, Andresen SM, Nebb HI, Madsen L, Kristiansen K, MacDougald OA. Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism. Mol Cell Biol 22(16):5989-99, 2002. e-Pub 2002. PMID: 12138207.
348. Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash SM, Cho KR. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res 62(16):4722-9, 2002. e-Pub 2002. PMID: 12183431.
349. Chen G, Gharib TG, Huang CC, Thomas DG, Shedden KA, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res 8(7):2298-305, 2002. e-Pub 2002. PMID: 12114434.
350. Grolleau A, Bowman J, Pradet-Balade B, Puravs E, Hanash SM, Garcia-Sanz JA, Beretta L. Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J Biol Chem 277(25):22175-84, 2002. e-Pub 2002. PMID: 11943782.
351. Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash SM, Cho KR, Fearon ER. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J Biol Chem 277(24):21657-65, 2002. e-Pub 2002. PMID: 11940574.
352. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1(4):304-13, 2002. e-Pub 2002. PMID: 12096112.
353. Girard S, Shalhoub P, Lescure P, Sabile A, Misek DE, Hanash SM, Bréchot C, Beretta L. An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 295(2):272-83, 2002. e-Pub 2002. PMID: 12033786.
354. Wimmer K, Zhu Xx XX, Rouillard JM, Ambros PF, Lamb BJ, Kuick R, Eckart M, Weinhäusl A, Fonatsch C, Hanash SM. Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma. Genes Chromosomes Cancer 33(3):285-94, 2002. e-Pub 2002. PMID: 11807986.
355. Le Naour F, Brichory F, Misek DE, Bréchot C, Hanash SM, Beretta L. A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Mol Cell Proteomics 1(3):197-203, 2002. e-Pub 2002. PMID: 12096119.
356. Li JY, Lescure PA, Misek DE, Lai YM, Chai BX, Kuick R, Thompson RC, Demo RM, Kurnit DM, Michailidis G, Hanash SM, Gantz I. Food deprivation-induced expression of minoxidil sulfotransferase in the hypothalamus uncovered by microarray analysis. J Biol Chem 277(11):9069-76, 2002. e-Pub 2002. PMID: 11782476.
357. Hanash SM, Beretta LM. Operomics: integrated genomic and proteomic profiling of cells and tissues. Brief Funct Genomic Proteomic 1(1):10-22, 2002. e-Pub 2002. PMID: 15251063.
358. Hanash SM, Bobek MP, Rickman DS, Williams T, Rouillard JM, Kuick R, Puravs E. Integrating cancer genomics and proteomics in the post-genome era. Proteomics 2(1):69-75, 2002. e-Pub 2002. PMID: 11788993.
359. Hanash SM, Petricoin E, Liotta L. A meeting of minds in proteomics. Proteomics 1(12):1475-8, 2001. e-Pub 2001. PMID: 11822353.
360. Ehrlich M, Buchanan KL, Tsien F, Jiang G, Sun B, Uicker W, Weemaes CM, Smeets D, Sperling K, Belohradsky BH, Tommerup N, Misek DE, Rouillard JM, Kuick R, Hanash SM. DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. Hum Mol Genet 10(25):2917-31, 2001. e-Pub 2001. PMID: 11741835.
361. Brichory F, Beer D, Le Naour F, Giordano T, Hanash SM. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res 61(21):7908-12, 2001. e-Pub 2001. PMID: 11691811.
362. Erson AE, Niell BL, DeMers SK, Rouillard JM, Hanash SM, Petty EM. Overexpressed genes/ESTs and characterization of distinct amplicons on 17q23 in breast cancer cells. Neoplasia 3(6):521-6, 2001. e-Pub 2001. PMID: 11774034.
363. Chang CL, Hora N, Huberman N, Hinderer R, Kukuruga M, Hanash SM. Oncoprotein 18 levels and phosphorylation mediate megakaryocyte polyploidization in human erythroleukemia cells. Proteomics 1(11):1415-23, 2001. e-Pub 2001. PMID: 11922601.
364. Le Naour F, Misek DE, Krause MC, Deneux L, Giordano TJ, Scholl S, Hanash SM. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res 7(11):3328-35, 2001. e-Pub 2001. PMID: 11705844.
365. Giordano TJ, Shedden KA, Schwartz DR, Kuick R, Taylor JM, Lee N, Misek DE, Greenson JK, Kardia SL, Beer DG, Rennert G, Cho KR, Gruber SB, Fearon ER, Hanash SM. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 159(4):1231-8, 2001. e-Pub 2001. PMID: 11583950.
366. Hanash SM. Mining the cancer proteome. Proteomics 1(10):1189-90, 2001. e-Pub 2001. PMID: 11721630.
367. Waghray A, Feroze F, Schober MS, Yao F, Wood C, Puravs E, Krause M, Hanash SM, Chen YQ. Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis. Proteomics 1(10):1327-38, 2001. e-Pub 2001. PMID: 11721644.
368. Oh JM, Brichory F, Puravs E, Kuick R, Wood C, Rouillard JM, Tra J, Kardia S, Beer D, Hanash SM. A database of protein expression in lung cancer. Proteomics 1(10):1303-19, 2001. e-Pub 2001. PMID: 11721642.
369. Madoz-Gúrpide J, Wang H, Misek DE, Brichory F, Hanash SM. Protein based microarrays: a tool for probing the proteome of cancer cells and tissues. Proteomics 1(10):1279-87, 2001. e-Pub 2001. PMID: 11721639.
370. Rickman DS, Bobek MP, Misek DE, Kuick R, Blaivas M, Kurnit DM, Taylor J, Hanash SM. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 61(18):6885-91, 2001. e-Pub 2001. PMID: 11559565.
371. Brichory FM, Misek DE, Yim AM, Krause MC, Giordano TJ, Beer DG, Hanash SM. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci U S A 98(17):9824-9, 2001. e-Pub 2001. PMID: 11504947.
372. Rouillard JM, Erson AE, Kuick R, Asakawa J, Wimmer K, Muleris M, Petty EM, Hanash SM. Virtual genome scan: a tool for restriction landmark-based scanning of the human genome. Genome Res 11(8):1453-9, 2001. e-Pub 2001. PMID: 11483587.
373. Bidon N, Brichory F, Hanash SM, Bourguet P, Dazord L, Le Pennec JP. Two messenger RNAs and five isoforms for Po66-CBP, a galectin-8 homolog in a human lung carcinoma cell line. Gene 274(1-2):253-62, 2001. e-Pub 2001. PMID: 11675018.
374. Yung R, Ray D, Eisenbraun JK, Deng C, Attwood J, Eisenbraun MD, Johnson K, Miller RA, Hanash SM, Richardson B. Unexpected effects of a heterozygous dnmt1 null mutation on age-dependent DNA hypomethylation and autoimmunity. J Gerontol A Biol Sci Med Sci 56(6):B268-76, 2001. e-Pub 2001. PMID: 11382789.
375. Hanash SM. 2-D or not 2-D--is there a future for 2-D gels in proteomics? Insights from the York proteomics meeting. Proteomics 1(5):635-7, 2001. e-Pub 2001. PMID: 11678032.
376. Le Naour F, Hohenkirk L, Grolleau A, Misek DE, Lescure P, Geiger JD, Hanash SM, Beretta L. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J Biol Chem 276(21):17920-31, 2001. e-Pub 2001. PMID: 11279020.
377. Charrin S, Le Naour F, Oualid M, Billard M, Faure G, Hanash SM, Boucheix C, Rubinstein E. The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J Biol Chem 276(17):14329-37, 2001. e-Pub 2001. PMID: 11278880.
378. Rickman DS, Tyagi R, Zhu XX, Bobek MP, Song S, Blaivas M, Misek DE, Israel MA, Kurnit DM, Ross DA, Kish PE, Hanash SM. The gene for the axonal cell adhesion molecule TAX-1 is amplified and aberrantly expressed in malignant gliomas. Cancer Res 61(5):2162-8, 2001. e-Pub 2001. PMID: 11280781.
379. Deng C, Kaplan MJ, Yang J, Ray D, Zhang Z, McCune WJ, Hanash SM, Richardson BC. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 44(2):397-407, 2001. e-Pub 2001. PMID: 11229472.
380. Wimmer K, Zhu XX, Lamb BJ, Kuick R, Ambros P, Kovar H, Thoraval D, Elkahloun A, Meltzer P, Hanash SM. Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma. Med Pediatr Oncol 36(1):75-9, 2001. e-Pub 2001. PMID: 11464910.
381. Grolleau A, Kaplan MJ, Hanash SM, Beretta L, Richardson B. Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients. J Clin Invest 106(12):1561-8, 2000. e-Pub 2000. PMID: 11120763.
382. Lin L, Prescott MS, Zhu Z, Singh P, Chun SY, Kuick RD, Hanash SM, Orringer MB, Glover TW, Beer DG. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. Cancer Res 60(24):7021-7, 2000. e-Pub 2000. PMID: 11156406.
383. Prasannan L, Misek DE, Hinderer R, Michon J, Geiger JD, Hanash SM. Identification of beta-tubulin isoforms as tumor antigens in neuroblastoma. Clin Cancer Res 6(10):3949-56, 2000. e-Pub 2000. PMID: 11051243.
384. Lin L, Aggarwal S, Glover TW, Orringer MB, Hanash SM, Beer DG. A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene. Cancer Res 60(5):1341-7, 2000. e-Pub 2000. PMID: 10728696.
385. Kondo T, Bobek MP, Kuick R, Lamb B, Zhu X, Narayan A, Bourc'his D, Viegas-Péquignot E, Ehrlich M, Hanash SM. Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. Hum Mol Genet 9(4):597-604, 2000. e-Pub 2000. PMID: 10699183.
386. Wall DB, Kachman MT, Gong S, Hinderer R, Parus S, Misek DE, Hanash SM, Lubman DM. Isoelectric focusing nonporous RP HPLC: a two-dimensional liquid-phase separation method for mapping of cellular proteins with identification using MALDI-TOF mass spectrometry. Anal Chem 72(6):1099-111, 2000. e-Pub 2000. PMID: 10740846.
387. Zhu X, Deng C, Kuick R, Yung R, Lamb B, Neel JV, Richardson B, Hanash SM. Analysis of human peripheral blood T cells and single-cell-derived T cell clones uncovers extensive clonal CpG island methylation heterogeneity throughout the genome. Proc Natl Acad Sci U S A 96(14):8058-63, 1999. e-Pub 1999. PMID: 10393947.
388. Schickle H, Lamb BJ, Hanash SM. Horizontal two-dimensional electrophoresis of complex DNA samples using precast gel systems. Electrophoresis 20(6):1233-8, 1999. e-Pub 1999. PMID: 10380763.
389. Soldes OS, Kuick RD, Thompson IA, Hughes SJ, Orringer MB, Iannettoni MD, Hanash SM, Beer DG. Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas. Br J Cancer 79(3-4):595-603, 1999. e-Pub 1999. PMID: 10027336.
390. Ferbus D, Fléchon A, Muleris M, Li Y, Hanash SM, Terris B, Hammel P, Pibouin L, Dutrillaux B, Goubin G. Amplification and over-expression of OZF, a gene encoding a zinc finger protein, in human pancreatic carcinomas. Int J Cancer 80(3):369-72, 1999. e-Pub 1999. PMID: 9935176.
391. Wimmer K, Zhu XX, Lamb BJ, Kuick R, Ambros PF, Kovar H, Thoraval D, Motyka S, Alberts JR, Hanash SM. Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma. Oncogene 18(1):233-8, 1999. e-Pub 1999. PMID: 9926938.
392. Chen Y, Jin X, Misek D, Hinderer R, Hanash SM, Lubman DM. Identification of proteins from two-dimensional gel electrophoresis of human erythroleukemia cells using capillary high performance liquid chromatography/electrospray-ion trap-reflectron time-of-flight mass spectrometry with two-dimensional topographic map analysis of in-gel tryptic digest products. Rapid Commun Mass Spectrom 13(19):1907-16, 1999. e-Pub 1999. PMID: 10487937.
393. Jin X, Chen Y, Lubman DM, Misek D, Hanash SM. Capillary electrophoresis/tandem mass spectrometry for analysis of proteins from two-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis. Rapid Commun Mass Spectrom 13(23):2327-34, 1999. e-Pub 1999. PMID: 10567930.
394. Curtis LJ, Li Y, Gerbault-Seureau M, Kuick R, Dutrillaux AM, Goubin G, Fawcett J, Cram S, Dutrillaux B, Hanash SM, Muleris M. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines. Genomics 53(1):42-55, 1998. e-Pub 1998. PMID: 9787076.
395. Hughes SJ, Glover TW, Zhu XX, Kuick R, Thoraval D, Orringer MB, Beer DG, Hanash SM. A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. Proc Natl Acad Sci U S A 95(21):12410-5, 1998. e-Pub 1998. PMID: 9770500.
396. Hanash SM, Teichroew D. Mining the human proteome: experience with the human lymphoid protein database. Electrophoresis 19(11):2004-9, 1998. e-Pub 1998. PMID: 9740061.
397. Deng C, Yang J, Scott J, Hanash SM, Richardson BC. Role of the ras-MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation. Biol Chem 379(8-9):1113-20, 1998. e-Pub 1998. PMID: 9792444.
398. Almeida A, Zhu XX, Vogt N, Tyagi R, Muleris M, Dutrillaux AM, Dutrillaux B, Ross D, Malfoy B, Hanash SM. GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas. Oncogene 16(23):2997-3002, 1998. e-Pub 1998. PMID: 9662332.
399. Beretta L, Singer NG, Hinderer R, Gingras AC, Richardson B, Hanash SM, Sonenberg N. Differential regulation of translation and eIF4E phosphorylation during human thymocyte maturation. J Immunol 160(7):3269-73, 1998. e-Pub 1998. PMID: 9531283.
400. Melhem R, Hailat N, Kuick R, Hanash SM. Quantitative analysis of Op18 phosphorylation in childhood acute leukemia. Leukemia 11(10):1690-5, 1997. e-Pub 1997. PMID: 9324290.
401. Diaz LA, Friedman AW, He X, Kuick RD, Hanash SM, Fox DA. Monocyte-dependent regulation of T lymphocyte activation through CD98. Int Immunol 9(9):1221-31, 1997. e-Pub 1997. PMID: 9310825.
402. Yang J, Deng C, Hemati N, Hanash SM, Richardson BC. Effect of mitogenic stimulation and DNA methylation on human T cell DNA methyltransferase expression and activity. J Immunol 159(3):1303-9, 1997. e-Pub 1997. PMID: 9233626.
403. Bradford CR, Zhu S, Poore J, Fisher SG, Beals TF, Thoraval D, Hanash SM, Carey TE, Wolf GT. p53 mutation as a prognostic marker in advanced laryngeal carcinoma. Department of Veterans Affairs Laryngeal Cancer Cooperative Study Group. Arch Otolaryngol Head Neck Surg 123(6):605-9, 1997. e-Pub 1997. PMID: 9193221.
404. Wimmer K, Thoraval D, Kuick R, Lamb BJ, Hanash SM. Identification of amplifications, deletions and methylation changes in cancer by means of two-dimensional analysis of genomic digests: application to neuroblastoma. Biochem Soc Trans 25(1):262-7, 1997. e-Pub 1997. PMID: 9056881.
405. Tsukiyama-Kohara K, Vidal SM, Gingras AC, Glover TW, Hanash SM, Heng H, Sonenberg N. Tissue distribution, genomic structure, and chromosome mapping of mouse and human eukaryotic initiation factor 4E-binding proteins 1 and 2. Genomics 38(3):353-63, 1996. e-Pub 1996. PMID: 8975712.
406. Wimmer K, Thoraval D, Asakawa J, Kuick R, Kodaira M, Lamb B, Fawcett J, Glover T, Cram S, Hanash SM. Two-dimensional separation and cloning of chromosome 1 NotI-EcoRV-derived genomic fragments. Genomics 38(2):124-32, 1996. e-Pub 1996. PMID: 8954793.
407. Thoraval D, Asakawa J, Wimmer K, Kuick R, Lamb B, Richardson B, Ambros P, Glover T, Hanash SM. Demethylation of repetitive DNA sequences in neuroblastoma. Genes Chromosomes Cancer 17(4):234-44, 1996. e-Pub 1996. PMID: 8946205.
408. Wimmer K, Kuick R, Thoraval D, Hanash SM. Two-dimensional separations of the genome and proteome of neuroblastoma cells. Electrophoresis 17(11):1741-51, 1996. e-Pub 1996. PMID: 8982607.
409. Kuick R, Asakawa J, Neel JV, Kodaira M, Satoh C, Thoraval D, Gonzalez IL, Hanash SM. Studies of the inheritance of human ribosomal DNA variants detected in two-dimensional separations of genomic restriction fragments. Genetics 144(1):307-16, 1996. e-Pub 1996. PMID: 8878694.
410. Hanash SM. A role for chromosome 1 in colorectal cancer. Gastroenterology 111(1):250-2, 1996. e-Pub 1996. PMID: 8698208.
411. Satoh C, Takahashi N, Asakawa J, Kodaira M, Kuick R, Hanash SM, Neel JV. Genetic analysis of children of atomic bomb survivors. Environ Health Perspect 104 Suppl 3:511-9, 1996. e-Pub 1996. PMID: 8781374.
412. Beretta L, Gabbay M, Berger R, Hanash SM, Sonenberg N. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias. Oncogene 12(7):1593-6, 1996. e-Pub 1996. PMID: 8622878.
413. Thoraval D, Asakawa J, Kodaira M, Chang C, Radany E, Kuick R, Lamb B, Richardson B, Neel JV, Glover T, Hanash SM. A methylated human 9-kb repetitive sequence on acrocentric chromosomes is homologous to a subtelomeric repeat in chimpanzees. Proc Natl Acad Sci U S A 93(9):4442-7, 1996. e-Pub 1996. PMID: 8633086.
414. Chang CL, Strahler JR, Thoraval DH, Qian MG, Hinderer R, Hanash SM. A nucleoside diphosphate kinase A (nm23-H1) serine 120-->glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction. Oncogene 12(3):659-67, 1996. e-Pub 1996. PMID: 8637723.
415. Qian MG, Zheng K, Chen Y, Chang CL, Hanash SM, Lubman DM. Capillary liquid chromatography coupled with an ion trap storage/reflectron time-of-flight mass spectrometer for structural confirmation of three recombinant protein isoforms. Rapid Commun Mass Spectrom 10(9):1079-87, 1996. e-Pub 1996. PMID: 8755237.
416. Sullivan KA, Castle VP, Hanash SM, Feldman EL. Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am J Pathol 147(6):1790-8, 1995. e-Pub 1995. PMID: 7495303.
417. Hailat NQ, Hanash SM. A technique for identification of cellular proteins by western immunoblotting and immunoautoradiography of 2-D PAGE. Indian J Biochem Biophys 32(5):240-4, 1995. e-Pub 1995. PMID: 8713743.
418. Vila LM, Haftel HM, Park HS, Lin MS, Romzek NC, Hanash SM, Holoshitz J. Expansion of mycobacterium-reactive gamma delta T cells by a subset of memory helper T cells. Infect Immun 63(4):1211-7, 1995. e-Pub 1995. PMID: 7890374.
419. Asakawa J, Kuick R, Neel JV, Kodaira M, Satoh C, Hanash SM. Quantitative and qualitative genetic variation in two-dimensional DNA gels of human lymphocytoid cell lines. Electrophoresis 16(2):241-52, 1995. e-Pub 1995. PMID: 7774565.
420. Hailata N, Johnson R, al-Bagdadi F, Hanash SM. Proliferating cell nuclear antigen expression in sheep infected with bovine leukemia virus. Vet Immunol Immunopathol 44(3-4):211-22, 1995. e-Pub 1995. PMID: 7747402.
421. Kuick R, Asakawa J, Neel JV, Satoh C, Hanash SM. High yield of restriction fragment length polymorphisms in two-dimensional separations of human genomic DNA. Genomics 25(2):345-53, 1995. e-Pub 1995. PMID: 7789966.
422. Haftel HM, Chang Y, Hinderer R, Hanash SM, Holoshitz J. Induction of the autoantigen proliferating cell nuclear antigen in T lymphocytes by a mycobacterial antigen. J Clin Invest 94(4):1365-72, 1994. e-Pub 1994. PMID: 7929811.
423. Asakawa J, Kuick R, Neel JV, Kodaira M, Satoh C, Hanash SM. Genetic variation detected by quantitative analysis of end-labeled genomic DNA fragments. Proc Natl Acad Sci U S A 91(19):9052-6, 1994. e-Pub 1994. PMID: 7916459.
424. Chang CL, Zhu XX, Thoraval DH, Ungar D, Rawwas J, Hora N, Strahler JR, Hanash SM, Radany E. Nm23-H1 mutation in neuroblastoma. Nature 370(6488):335-6, 1994. e-Pub 1994. PMID: 8047138.
425. Ungar DR, Hailat N, Strahler JR, Kuick RD, Brodeur GM, Seeger RC, Reynolds CP, Hanash SM. Hsp27 expression in neuroblastoma: correlation with disease stage. J Natl Cancer Inst 86(10):780-4, 1994. e-Pub 1994. PMID: 8169976.
426. Hanash SM, Beretta L, Barcroft CL, Sheldon S, Glover TW, Ungar D, Sonenberg N. Mapping of the gene for interferon-inducible dsRNA-dependent protein kinase to chromosome region 2p21-22: a site of rearrangements in myeloproliferative disorders. Genes Chromosomes Cancer 8(1):34-7, 1993. e-Pub 1993. PMID: 7691157.
427. Wang YK, Liao PC, Allison J, Gage DA, Andrews PC, Lubman DM, Hanash SM, Strahler JR. Phorbol 12-myristate 13-acetate-induced phosphorylation of Op18 in Jurkat T cells. Identification of phosphorylation sites by matrix-assisted laser desorption ionization mass spectrometry. J Biol Chem 268(19):14269-77, 1993. e-Pub 1993. PMID: 8314790.
428. Strahler JR, Zhu XX, Hora N, Wang YK, Andrews PC, Roseman NA, Neel JV, Turka L, Hanash SM. Maturation stage and proliferation-dependent expression of dUTPase in human T cells. Proc Natl Acad Sci U S A 90(11):4991-5, 1993. e-Pub 1993. PMID: 8389461.
429. Hanash SM, Strahler JR, Chan Y, Kuick R, Teichroew D, Neel JV, Hailat N, Keim DR, Gratiot-Deans J, Ungar D. Data base analysis of protein expression patterns during T-cell ontogeny and activation. Proc Natl Acad Sci U S A 90(8):3314-8, 1993. e-Pub 1993. PMID: 8475073.
430. Turka LA, Gratiot-Deans J, Keim D, Bandukwala R, Green J, Strahler J, Hanash SM. Elevated proliferating cell nuclear antigen levels in immature thymocytes. Dissociation from cell cycle progression. J Immunol 150(7):2746-52, 1993. e-Pub 1993. PMID: 8095955.
431. Keim DR, Hailat N, Kuick R, Reynolds CP, Brodeur GM, Seeger RC, Hanash SM. PCNA levels in neuroblastoma are increased in tumors with an amplified N-myc gene and in metastatic stage tumors. Clin Exp Metastasis 11(1):83-90, 1993. e-Pub 1993. PMID: 8093685.
432. Gratiot-Deans J, Keim D, Strahler JR, Turka LA, Hanash SM. Differential expression of Op18 phosphoprotein during human thymocyte maturation. J Clin Invest 90(4):1576-81, 1992. e-Pub 1992. PMID: 1401087.
433. Kuick RD, Neel JV, Strahler JR, Chu EH, Bargal R, Fox DA, Hanash SM. Similarity of spontaneous germinal and in vitro somatic cell mutation rates in humans: implications for carcinogenesis and for the role of exogenous factors in "spontaneous" germinal mutagenesis. Proc Natl Acad Sci U S A 89(15):7036-40, 1992. e-Pub 1992. PMID: 1495998.
434. Richardson BC, Strahler JR, Pivirotto TS, Quddus J, Bayliss GE, Gross LA, O'Rourke KS, Powers D, Hanash SM, Johnson MA. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum 35(6):647-62, 1992. e-Pub 1992. PMID: 1376122.
435. Strahler JR, Lamb BJ, Ungar DR, Fox DA, Hanash SM. Cell cycle progression is associated with distinct patterns of phosphorylation of Op18. Biochem Biophys Res Commun 185(1):197-203, 1992. e-Pub 1992. PMID: 1376116.
436. Keim D, Hailat N, Melhem R, Zhu XX, Lascu I, Veron M, Strahler J, Hanash SM. Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase. J Clin Invest 89(3):919-24, 1992. e-Pub 1992. PMID: 1311721.
437. Strahler JR, Hailat N, LAmb BJ, Rogers KP, Underhill J, Melhem RF, Keim DR, Zhu XX, Kuick RD, Fox DA, and Hanash SM. Activation of peripheral blood lymphocytes through the T cell receptor induces rapid phosphorylation of Op18. J Immunol 149:1191-1198, 1992. e-Pub 1992.
438. Ali I, Chan Y, Kuick R, Teichroew D, Hanash SM. Implementation of a two-dimensional electrophoresis-related laboratory information processing system: database aspects. Electrophoresis 12(10):747-61, 1991. e-Pub 1991. PMID: 1802692.
439. Kuick RD, Skolnick MM, Hanash SM, Neel JV. A two-dimensional electrophoresis-related laboratory information processing system: spot matching. Electrophoresis 12(10):736-46, 1991. e-Pub 1991. PMID: 1802691.
440. Melhem RF, Zhu XX, Hailat N, Strahler JR, Hanash SM. Characterization of the gene for a proliferation-related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia. J Biol Chem 266(27):17747-53, 1991. e-Pub 1991. PMID: 1917919.
441. Görg A, Postel W, Friedrich C, Kuick R, Strahler JR, Hanash SM. Temperature-dependent spot positional variability in two-dimensional polypeptide patterns. Electrophoresis 12(9):653-8, 1991. e-Pub 1991. PMID: 1752246.
442. Melhem RF, Strahler JR, Hailat N, Zhu XX, Hanash SM. Involvement of OP18 in cell proliferation. Biochem Biophys Res Commun 179(3):1649-55, 1991. e-Pub 1991. PMID: 1930203.
443. Hanash SM, Strahler JR, Neel JV, Hailat N, Melhem R, Keim D, Zhu XX, Wagner D, Gage DA, Watson JT. Highly resolving two-dimensional gels for protein sequencing. Proc Natl Acad Sci U S A 88(13):5709-13, 1991. e-Pub 1991. PMID: 2062849.
444. Strahler JR, Kuick R, Hanash SM. Diminished phosphorylation of a heat shock protein (HSP 27) in infant acute lymphoblastic leukemia. Biochem Biophys Res Commun 175(1):134-42, 1991. e-Pub 1991. PMID: 1998499.
445. Bielinska A, Baier L, Hailat N, Strahler JR, Nabel GJ, Hanash SM. Expression of a novel nuclear protein in activated and in tat-I expressing T cells. J Immunol 146(3):1031-6, 1991. e-Pub 1991. PMID: 1988491.
446. Watson JT, Wagner DS, Chang YS, Strahler JR, Hanash SM, and Gage D. Characterization of the ethyl-triphenylphosphonium derivative of model peptides by fast atom bombardment collisionally-activited dissociation tandem mass spectrometry using B/E linked scans. Int J Mass Spect Ion Processes 111:191-209, 1991. e-Pub 1991.
447. Strahler JR, and Hanash SM. Immobilized pH gradients: Analytical and Preparative Use. Methods: A Companion to Methods in Enzymology 3:109-114, 1991. e-Pub 1991.
448. Kuick R, Skolnick M, Neel JV, and Hanash SM. An automatic spot matching algorithm for two- dimensional electrophoresis. Electrophoresis 12:736-746, 1991. e-Pub 1991.
449. Hailat N, Keim D, Melhem R, Zhu X, Eckerson C, Brodeur G, Reynolds CP, Seegar RC, Lottspeich F, Strahler JR, and Hanash SM. High Levels of P19/NM23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 88:341-345, 1991. e-Pub 1991.
450. Ali I, Chan Y, Kuick R, Teichroew D, Hanash SM. Implemenation of a laboratory information processing system. Electrophoresis 12:747-761, 1991. e-Pub 1991.
451. Hailat N, Strahler J, Melhem R, Zhu XX, Brodeur G, Seeger RC, Reynolds CP, Hanash SM. N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18). Oncogene 5(11):1615-8, 1990. e-Pub 1990. PMID: 2267130.
452. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash SM, Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 33(11):1665-73, 1990. e-Pub 1990. PMID: 2242063.
453. Keim D, Hailat N, Hodge D, Hanash SM. Proliferating cell nuclear antigen expression in childhood acute leukemia. Blood 76(5):985-90, 1990. e-Pub 1990. PMID: 1975505.
454. Ferrari AC, Seuanez HN, Hanash SM, Atweh GF. A gene that encodes for a leukemia-associated phosphoprotein (p18) maps to chromosome bands 1p35-36.1. Genes Chromosomes Cancer 2(2):125-9, 1990. e-Pub 1990. PMID: 2278968.
455. Stahler J, Hanash SM, Kuick R, Eckerskorn C, Lottspeich F, Richardson B, Fox D, Stoolman L, Hanson C, Nichols D, and Tueche HJ. Identification of two related markers for common acute lymphoblastic leukemia as heat shock proteins. J Clin Invest 85:200-207, 1990. e-Pub 1990.
456. Zhu XX, Kozarsky K, Strahler JR, Eckerskorn C, Lottspeich F, Melhem R, Lowe J, Fox DA, Hanash SM, Atweh GF. Molecular cloning of a novel human leukemia-associated gene. Evidence of conservation in animal species. J Biol Chem 264(24):14556-60, 1989. e-Pub 1989. PMID: 2760073.
457. Hanash SM, Strahler JR. Advances in two-dimensional electrophoresis. Nature 337(6206):485-6, 1989. e-Pub 1989. PMID: 2915694.
458. Hanash SM, Kuick R, Strahler J, Richardson B, Reaman G, Stoolman L, Hanson C, Nichols D, Tueche HJ. Identification of a cellular polypeptide that distinguishes between acute lymphoblastic leukemia in infants and in older children. Blood 73(2):527-32, 1989. e-Pub 1989. PMID: 2917188.
459. Hanash SM, Kuick R, Nichols D, Stoolman L. Quantitative analysis of a new marker for common acute lymphoblastic leukemia detected by two-dimensional electrophoresis. Dis Markers 6(4):209-20, 1988. e-Pub 1988. PMID: 2976630.
460. Hanash SM, Strahler JR, Kuick R, Chu EH, Nichols D. Identification of a polypeptide associated with the malignant phenotype in acute leukemia. J Biol Chem 263(26):12813-5, 1988. e-Pub 1988. PMID: 3417633.
461. Richardson B, Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash SM. N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide. Arthritis Rheum 31(8):995-9, 1988. e-Pub 1988. PMID: 2457378.
462. Chu EH, Boehnke M, Hanash SM, Kuick RD, Lamb BJ, Neel JV, Niezgoda W, Pivirotto S, Sundling G. Estimation of mutation rates based on the analysis of polypeptide constituents of cultured human lymphoblastoid cells. Genetics 119(3):693-703, 1988. e-Pub 1988. PMID: 3402732.
463. Robertson PL, Aldrich MS, Hanash SM, Goldstein GW. Stroke associated with obstructive sleep apnea in a child with sickle cell anemia. Ann Neurol 23(6):614-6, 1988. e-Pub 1988. PMID: 3408243.
464. Kuick RD, Hanash SM, Strahler JR. Somatic mutation studies in human lymphoid cells: the detectability of quantitative genetic variants in two-dimensional gels. Electrophoresis 9(4):192-8, 1988. e-Pub 1988. PMID: 3234354.
465. Strahler JR, Hanash SM, Somerlot L, Bjellqvist B, Görg A. Effect of salt on the performance of immobilized pH gradient isoelectric focusing gels. Electrophoresis 9(2):74-80, 1988. e-Pub 1988. PMID: 3234340.
466. Hanash SM, Boehnke M, Chu EH, Neel JV, Kuick RD. Nonrandom distribution of structural mutants in ethylnitrosourea-treated cultured human lymphoblastoid cells. Proc Natl Acad Sci U S A 85(1):165-9, 1988. e-Pub 1988. PMID: 3422414.
467. Görg A, Postel W, Günther S, Weser J, Strahler JR, Hanash SM, Somerlot L, Kuick R. Approach to stationary two-dimensional pattern: influence of focusing time and immobiline/carrier ampholytes concentrations. Electrophoresis 9(1):37-46, 1988. e-Pub 1988. PMID: 2466646.
468. Cornacchia E, Golbus J, Maybaum J, Strahler JR, Hanash SM, and Richardson B. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 140:2197-2200, 1988. e-Pub 1988.
469. Richardson BC, Cornacchia E, Golbus J, Maybaum J, Strahler JR, and Hanash SM. Nacetyprocainamide is a less potent inducer of T cell autoreactivity than procainamide. Arth Rheum 31:995-999, 1988. e-Pub 1988.
470. Chu EH, Boehnke M, Hanash SM, Kuick R, Lamb B, Neel JV, Niezgoda W, Povirotto S, and Sundling G. Estimation of somatic mutation rates and demonstration of nonrandomness of mutagenesis in human cells. Environ Mol Mutagen 11( Suppl.11):23, 1988. e-Pub 1988.
471. Schneider J, Erickson RP, Hanash SM. Mouse testicular protein variants, including tubulin, detected by isoelectrofocusing two-dimensional gel electrophoresis. Genet Res 50(3):225-33, 1987. e-Pub 1987. PMID: 3443294.
472. Strahler JR, Rosenblum BB, Hanash SM. Identification and characterization of a human transthyretin variant. Biochem Biophys Res Commun 148(1):471-7, 1987. e-Pub 1987. PMID: 3675594.
473. Boerwinkle E, Visvikis S, Welsh D, Steinmetz J, Hanash SM, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals. Am J Med Genet 27(3):567-82, 1987. e-Pub 1987. PMID: 3631131.
474. Gorg A, Postel W, Weser J, Strahler JR, and Hanash SM. Horizontal two -dimensional gel electrophresis with immobilized pH gradients in the first dimension, in the presence of non ionic detergent. Electrophoresis 8:45-51, 1987. e-Pub 1987.
475. Hanash SM, Chu EH, Kuick R, Skolnick M, Neel J, Strahler J, Pivirotto S, Niezgoda W. Detection of human somatic cell structural gene mutations by two-dimensional electrophoresis. Proteins 2(1):13-9, 1987. e-Pub 1987. PMID: 3328857.
476. Hanash SM, Strahler JR, somerlot L, and Gorg A. Two- dimensional electrophoresis with immobilised pH gradients in the first dimension, protein focusing as a function of time. Electrophoresis 8:229-234, 1987. e-Pub 1987.
477. Kuick R, Hanash SM, Chu EH, and Strahler JR. A comparison of some adjustment techniques for use with quantitative sot data from two-dimensional gels. Electrophoresis 8:199-204, 1987. e-Pub 1987.
478. Strahler JR, Hanash SM, Somerlot L, Gorg A, Weser J, and Postel W. High resolution two-dimensional polyacrylamide gel electrophoresis of basic polypeptides: Use of immobilized pH gradients in the first dimension. Electrophoresis 8:165-173, 1987. e-Pub 1987.
479. Hanash SM, Baier LJ, Welch D, Kuick R, Galteau M. Genetic variants detected among 106 lymphocyte polypeptides observed in two-dimensional gels. Am J Hum Genet 39(3):317-28, 1986. e-Pub 1986. PMID: 3766538.
480. Cossu G, Manca M, Strahler JR, Hanash SM, Righetti PG. Detection of electrophoretically silent mutations by immobilized pH gradients. J Chromatogr 361:223-9, 1986. e-Pub 1986. PMID: 3733954.
481. Hanash SM, Baier LJ. Two-dimensional gel electrophoresis of cellular proteins reveals myeloid origin of blasts in two children with otherwise undifferentiated leukemia. Cancer 57(8):1539-43, 1986. e-Pub 1986. PMID: 3456254.
482. Hanash SM, Neel JV, Baier LJ, Rosenblum BB, Niezgoda W, Markel D. Genetic analysis of thirty-three platelet polypeptides detected in two-dimensional polyacrylamide gels. Am J Hum Genet 38(3):352-60, 1986. e-Pub 1986. PMID: 3953575.
483. Kuick R, Boerwinkle E, Hanash SM, Sing CF. A statistical analysis of spot variation using the two-dimensional polyacrylamide gel electrophoresis. Comput Biomed Res 19(1):90-102, 1986. e-Pub 1986. PMID: 3948498.
484. Hanash SM, Baier LJ, McCurry L, Schwartz SA. Lineage-related polypeptide markers in acute lymphoblastic leukemia detected by two-dimensional gel electrophoresis. Proc Natl Acad Sci U S A 83(3):807-11, 1986. e-Pub 1986. PMID: 3484825.
485. Rosenblum BB, Strahler JR, Hanash SM, Whitten CF, Butkunas-Puskorius R, Roberts A. Peripheral blood erythroid progenitors from patients with sickle cell anemia: HPLC separation of hemoglobins and the effect of a HbF switching factor. Prog Clin Biol Res 191:397-410, 1985. e-Pub 1985. PMID: 2413478.
486. Neel JV, Baier L, Hanash SM, Erickson RP. Frequency of polymorphisms for alleles encoding for proteins of domesticated mice. J Hered 76(5):314-320, 1985. e-Pub 1985. PMID: 4056362.
487. Hanash SM, Gagnon M, Seeger RC, Baier L. Analysis of neuroblastoma cell proteins using two-dimensional electrophoresis. Prog Clin Biol Res 175:261-8, 1985. e-Pub 1985. PMID: 3991732.
488. Aster JC, Brewer GJ, Hanash SM, Maisel H. Band 4.1-like proteins of the bovine lens. Effects of differentiation, distribution and extraction characteristics. Biochem J 224(2):609-16, 1984. e-Pub 1984. PMID: 6517866.
489. Rosenblum BB, Neel JV, Hanash SM, Joseph JL, Yew N. Identification of genetic variants in erythrocyte lysate by two-dimensional gel electrophoresis. Am J Hum Genet 36(3):601-12, 1984. e-Pub 1984. PMID: 6203403.
490. Baier LJ, Hanash SM, Erickson RP. Mice homozygous for chromosomal deletions at the albino locus region lack specific polypeptides in two-dimensional gels. Proc Natl Acad Sci U S A 81(7):2132-6, 1984. e-Pub 1984. PMID: 6585792.
491. Aster JC, Rosenblum BB, Brewer GJ, Hanash SM. Analysis of protein 4.1 structural variation using 2-dimensional polyacrylamide gel electrophoresis. Prog Clin Biol Res 159:73-88, 1984. e-Pub 1984. PMID: 6382326.
492. Gupta SP, Hanash SM. Separation of hemoglobin types by cation-exchange high-performance liquid chromatography. Anal Biochem 134(1):117-21, 1983. e-Pub 1983. PMID: 6660481.
493. Strahler JR, Rosenbloom BB, Hanash SM. A silent, neutral substitution detected by reverse-phase high-performance liquid chromatography: hemoglobin Beirut. Science 221(4613):860-2, 1983. e-Pub 1983. PMID: 6879181.
494. Rosenblum BB, Neel JV, Hanash SM. Two-dimensional electrophoresis of plasma polypeptides reveals "high" heterozygosity indices. Proc Natl Acad Sci U S A 80(16):5002-6, 1983. e-Pub 1983. PMID: 6576372.
495. Strahler JR, Rosenblum BB, Hanash SM, Butkunas R. Separation of transferrin types in human plasma by anion-exchange high-performance liquid chromatography. J Chromatogr 266:281-291, 1983. e-Pub 1983. PMID: 6630354.
496. Rosenblum BB, Hanash SM, Yew N, Neel JV. Two-dimensional electrophoretic analysis of erythrocyte membranes. Clin Chem 28(4 Pt 2):925-31, 1982. e-Pub 1982. PMID: 7074884.
497. Hanash SM, Tubergen DG, Heyn RM, Neel JV, Sandy L, Stevens GS, Rosenblum BB, Krzesicki RF. Two-dimensional gel electrophoresis of cell proteins in childhood leukemia, with silver staining: a preliminary report. Clin Chem 28(4 Pt 2):1026-30, 1982. e-Pub 1982. PMID: 6951652.
498. Amanullah A, Hanash SM, Bunnell K, Strahler J, Rucknagel DL, Ferruci SJ. Cord blood screening for hemoglobin disorders by high performance liquid chromatography. Anal Biochem 123(2):402-407, 1982. e-Pub 1982. PMID: 7125213.
499. Hanash SM, Kavadella M, Amanullah A, Scheller K, Bunnell K. High performance liquid chromatography of hemoglobins: factors affecting resolution. Prog Clin Biol Res 60:53-67, 1981. e-Pub 1981. PMID: 6169093.
500. Rucknagel DL, LaDu CS, Reynolds FJ, Hanash SM, Surtshin S, Whitten CW. Immunologic quantification of fetal hemoglobin in sickle cell anemia. Prog Clin Biol Res 60:135-47, 1981. e-Pub 1981. PMID: 6169089.
501. Hanash SM, Shapiro DN. Separation of human hemoglobins by ion exchange high performance liquid chromatography. Hemoglobin 5(2):165-75, 1981. e-Pub 1981. PMID: 7216816.
502. Hanash SM, Rucknagel DL, Heidelberger KP, Radin NS. Primary amyloidosis associated with Gaucher's disease. Ann Intern Med 89(5 Pt 1):639-641, 1978. e-Pub 1978. PMID: 717933.
503. Hanash SM, Rucknagel DL. Proteolytic activity in erythrocyte precursors. Proc Natl Acad Sci U S A 75(7):3427-31, 1978. e-Pub 1978. PMID: 277945.
504. Rucknagel DL, Baine RM, Hanash SM, Winter WP. Polymorphism in the number of hemoglobin alpha-chain loci and mechanisms governing the balance of chain synthesis. Prog Clin Biol Res 21:63-78, 1978. e-Pub 1978. PMID: 662911.
505. Hanash SM, Winter WP, Rucknagel DL. Synthesis of haemoglobin Wayne in erythroid cells. Nature 269(5630):717-9, 1977. e-Pub 1977. PMID: 593335.

Review Articles

1. León-Letelier RA, Dou R, Vykoukal J, Yip-Schneider MT, Maitra A, Irajizad E, Wu R, Dennison JB, Do KA, Zhang J, Schmidt CM, Hanash S, Fahrmann JF. Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. Clin Chem 70(1):102-115, 2024. e-Pub 2024. PMID: 38175578.
2. Khorami-Sarvestani S, Hanash SM, Fahrmann JF, León-Letelier RA, Katayama H. Glycosylation in cancer as a source of biomarkers. Expert Rev Proteomics 21(9-10):345-365, 2024. e-Pub 2024. PMID: 39376081.
3. Chen Y, León-Letelier RA, Abdel Sater AH, Vykoukal J, Dennison JB, Hanash S, Fahrmann JF. c-MYC-Driven Polyamine Metabolism in Ovarian Cancer: From Pathogenesis to Early Detection and Therapy. Cancers (Basel) 15(3), 2023. e-Pub 2023. PMID: 36765581.
4. León-Letelier RA, Dou R, Vykoukal J, Sater AHA, Ostrin E, Hanash S, Fahrmann JF. The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer. Front Oncol 13:1256769, 2023. e-Pub 2023. PMID: 37876966.
5. León-Letelier RA, Katayama H, Hanash S. Mining the Immunopeptidome for Antigenic Peptides in Cancer. Cancers (Basel) 14(20), 2022. e-Pub 2022. PMID: 36291752.
6. Kato T, Vykoukal JV, Fahrmann JF, Hanash S. Extracellular Vesicles in Lung Cancer: Prospects for Diagnostic and Therapeutic Applications. Cancers (Basel) 13(18), 2021. e-Pub 2021. PMID: 34572829.
7. Kobayashi M, Katayama H, Fahrmann JF, Hanash SM. Development of autoantibody signatures for common cancers. Semin Immunol 47:101388, 2020. e-Pub 2020. PMID: 31924500.
8. Jolly MK, Somarelli JA, Sheth M, Biddle A, Tripathi SC, Armstrong AJ, Hanash SM, Bapat SA, Rangarajan A, Levine H. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas. Pharmacol Ther 194:161-184, 2019. e-Pub 2019. PMID: 30268772.
9. Tripathi SC, Fahrmann JF, Vykoukal JV, Dennison JB, Hanash S. Targeting metabolic vulnerabilities of cancer: Small molecule inhibitors in clinic. Cancer Rep (Hoboken) 2(1):e1131, 2019. e-Pub 2019. PMID: 32721114.
10. Jolly MK, Tripathi SC, Somarelli JA, Hanash SM, Levine H. Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?. Mol Oncol 11(7):739-754, 2017. e-Pub 2017. PMID: 28548388.
11. Sun N, Taguchi A, Hanash SM. Switching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker Studies. J Clin Med 5(12), 2016. e-Pub 2016. PMID: 27916872.
12. Tsou P, Katayama H, Ostrin EJ, Hanash SM. The Emerging Role of B Cells in Tumor Immunity. Cancer Res 76(19):5597-5601. e-Pub 2016. PMID: 27634765.
13. Hanash SM, Baik CS, Kallioniemi O. Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol 8(3):142-50, 2011. e-Pub 2011. PMID: 21364687.
14. Zhang Q, Faca V, Hanash SM. Mining the plasma proteome for disease applications across seven logs of protein abundance. J Proteome Res 10(1):46-50, 2011. e-Pub 2011. PMID: 21062094.
15. Pitteri S, Hanash SM. A systems approach to the proteomic identification of novel cancer biomarkers. Dis Markers 28(4):233-9, 2010. e-Pub 2010. PMID: 20534908.
16. Harsha HC, Kandasamy K, Ranganathan P, Rani S, Ramabadran S, Gollapudi S, Balakrishnan L, Dwivedi SB, Telikicherla D, Selvan LD, Goel R, Mathivanan S, Marimuthu A, Kashyap M, Vizza RF, Mayer RJ, Decaprio JA, Srivastava S, Hanash SM, Hruban RH, Pandey A. A compendium of potential biomarkers of pancreatic cancer. PLoS Med 6(4):e1000046, 2009. e-Pub 2009. PMID: 19360088.
17. Qiu J, Hanash SM. Autoantibody profiling for cancer detection. Clin Lab Med 29(1):31-46, 2009. e-Pub 2009. PMID: 19389549.
18. Faça VM, Hanash SM. In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding. Cancer Res 69(3):728-30, 2009. e-Pub 2009. PMID: 19155298.
19. Ehrlich M, Sanchez C, Shao C, Nishiyama R, Kehrl J, Kuick R, Kubota T, Hanash SM. ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation. Autoimmunity 41(4):253-71, 2008. e-Pub 2008. PMID: 18432406.
20. Hanash SM, Pitteri SJ, Faca VM. Mining the plasma proteome for cancer biomarkers. Nature 452(7187):571-9, 2008. e-Pub 2008. PMID: 18385731.
21. Faca V, Krasnoselsky A, Hanash SM. Innovative proteomic approaches for cancer biomarker discovery. Biotechniques 43(3):279, 281-3, 285, 2007. e-Pub 2007. PMID: 17907570.
22. Kuick R, Misek DE, Monsma DJ, Webb CP, Wang H, Peterson KJ, Pisano M, Omenn GS, Hanash SM. Discovery of cancer biomarkers through the use of mouse models. Cancer Lett 249(1):40-8, 2007. e-Pub 2007. PMID: 17320282.
23. Davis MA, Hanash SM. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy. Breast Cancer Res 8(6):217, 2006. e-Pub 2006. PMID: 17184556.
24. Wang H, Hanash SM. Intact-protein based sample preparation strategies for proteome analysis in combination with mass spectrometry. Mass Spectrom Rev 24(3):413-26, 2005. e-Pub 2005. PMID: 15389852.
25. Steel LF, Haab BB, Hanash SM. Methods of comparative proteomic profiling for disease diagnostics. J Chromatogr B Analyt Technol Biomed Life Sci 815(1-2):275-84, 2005. e-Pub 2005. PMID: 15652816.
26. Misek DE, Imafuku Y, Hanash SM. Application of proteomic technologies to tumor analysis. Pharmacogenomics 5(8):1129-37, 2004. e-Pub 2004. PMID: 15584879.
27. Nakamura K, Aebersold R, Bairoch A, Dunn M, Celis J, Hanash SM, Hochstrasser D, Humphrey-Smith I, James P, Klose J, LaBaer J, Langen H, Mann M, Parekh R, Patterson S, Pearce C, Poepstorff P, Simpson RJ, Tomlinson I, Tsugita A, Yates J. [From genome to proteome--aim of human proteomics]. Seikagaku 76(10):1271-4, 2004. e-Pub 2004. PMID: 15580857.
28. Hanash SM. Integrated global profiling of cancer. Nat Rev Cancer 4(8):638-44, 2004. e-Pub 2004. PMID: 15286743.
29. Hanash SM. HUPO initiatives relevant to clinical proteomics. Mol Cell Proteomics 3(4):298-301, 2004. e-Pub 2004. PMID: 14747694.
30. Qiu J, Madoz-Gurpide J, Misek DE, Kuick R, Brenner DE, Michailidis G, Haab BB, Omenn GS, Hanash SM. Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J Proteome Res 3(2):261-7, 2004. e-Pub 2004. PMID: 15113102.
31. Hanash SM. Building a foundation for the human proteome: the role of the Human Proteome Organization. J Proteome Res 3(2):197-9, 2004. e-Pub 2004. PMID: 15113094.
32. Imafuku Y, Omenn GS, Hanash SM. Proteomics approaches to identify tumor antigen directed autoantibodies as cancer biomarkers. Dis Markers 20(3):149-53, 2004. e-Pub 2004. PMID: 15502247.
33. Wang H, Hanash SM. Multi-dimensional liquid phase based separations in proteomics. J Chromatogr B Analyt Technol Biomed Life Sci 787(1):11-8, 2003. e-Pub 2003. PMID: 12659729.
34. Madoz-Gurpide J, Hanash SM. Molecular analysis of cancer using DNA and protein microarrays. Adv Exp Med Biol 532:51-8, 2003. e-Pub 2003. PMID: 12908549.
35. Richards J, Le Naour F, Hanash SM, Beretta L. Integrated genomic and proteomic analysis of signaling pathways in dendritic cell differentiation and maturation. Ann N Y Acad Sci 975:91-100, 2002. e-Pub 2002. PMID: 12538157.
36. Shin BK, Wang H, Hanash SM. Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer. J Mammary Gland Biol Neoplasia 7(4):407-13, 2002. e-Pub 2002. PMID: 12882525.
37. Naour FL, Brichory F, Beretta L, Hanash SM. Identification of tumor-associated antigens using proteomics. Technol Cancer Res Treat 1(4):257-62, 2002. e-Pub 2002. PMID: 12625784.
38. Wang H, Hanash SM. Contributions of proteome profiling to the molecular analysis of cancer. Technol Cancer Res Treat 1(4):237-46, 2002. e-Pub 2002. PMID: 12625782.
39. Hanash SM, Celis JE. The Human Proteome Organization: a mission to advance proteome knowledge. Mol Cell Proteomics 1(6):413-4, 2002. e-Pub 2002. PMID: 12169681.
40. Hanash SM, Madoz-Gurpide J, Misek DE. Identification of novel targets for cancer therapy using expression proteomics. Leukemia 16(4):478-85, 2002. e-Pub 2002. PMID: 11960325.
41. Hanash SM. Global profiling of gene expression in cancer using genomics and proteomics. Curr Opin Mol Ther 3(6):538-45, 2001. e-Pub 2001. PMID: 11804268.
42. Srinivas PR, Srivastava S, Hanash SM, Wright GL. Proteomics in early detection of cancer. Clin Chem 47(10):1901-11, 2001. e-Pub 2001. PMID: 11568117.
43. Verma M, Wright GL, Hanash SM, Gopal-Srivastava R, Srivastava S. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Ann N Y Acad Sci 945:103-15, 2001. e-Pub 2001. PMID: 11708463.
44. Hanash SM, Brichory F, Beer D. A proteomic approach to the identification of lung cancer markers. Dis Markers 17(4):295-300, 2001. e-Pub 2001. PMID: 11790896.
45. Hanash SM. Operomics: molecular analysis of tissues from DNA to RNA to protein. Clin Chem Lab Med 38(9):805-13, 2000. e-Pub 2000. PMID: 11097332.
46. Hanash SM. Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: current status. Electrophoresis 21(6):1202-9, 2000. e-Pub 2000. PMID: 10786892.
47. Oh JM, Hanash SM, Teichroew D. Mining protein data from two-dimensional gels: tools for systematic post-planned analyses. Electrophoresis 20(4-5):766-74, 1999. e-Pub 1999. PMID: 10344246.
48. Hanash SM, Rucknagel DL. Clinical implications of recent advances in hemoglobin disorders. Med Clin North Am 64(4):775-800, 1980. e-Pub 1980. PMID: 6157060.
49. Winter WP, Hanash SM, Rucknagel DL. Genetic mechanisms contributing to the expression of the human hemoglogin loci. Adv Hum Genet 9:229-91, 361-7, 1979. e-Pub 1979. PMID: 393093.

Editorials

1. Hanash S. Lung cancer susceptibility beyond smoking history: opportunities and challenges. Transl Lung Cancer Res 11(7):1230-1232, 2022. PMID: 35958329.

Book Chapters

1. Wang H, Hanash SM. Intact Protein Analysis System for discovery of serum-based disease biomarkers. In: Serum Plasma Proteomics. Humana Press, 2011.
2. Wang H, and Hanash SM. Electrospray mass spectrometry for quantitative plasma profiling. In: Proteomics, Methods and Protocols. Humana Press, 2009.
3. Hanash SM. Translational implications of proteomics. In: Handbook of Cell Signaling. Elsevier, 2009.
4. Faca V, Wang H, and Hanash SM. Proteomic global profiling for cancer biomarker discovery. In: Mass specrometry of proteins and peptides. Humana Press, 2009.
5. Hanash SM. Proteomics technologies. In: Systems Biomedicine. Elseviers, 2009.
6. Hanash SM. Current proteomics. In: Essentials of Genomics and Bioinformatics. Wiley, 2006.
7. Creighton C, and Hanash SM. Informatics tools for functional pathway analysis using genomics and proteomics. In: Informatics in proteomics. Taylor and Francis, 2005.
8. Hanash SM. Application of proteomics to disease diagnostics. In: Molecular Diagnostics, 2005.
9. Hanash SM. Diagnostic applications of protein microarrays. In: Medical Biomethods Handbook, 2005.
10. Hanash SM. The role of proteomic analyses in breast cancer. In: Diseases of the 3rd Edition. Lippincott, Williams & Wilkins, 427-431, 2004.
11. Hanash SM. Clinical applications of proteomics. In: Proteome Analysis: Interpreting the Genome. Elsevier Science B.V, 225-237, 2004.
12. Hanash SM, Richard B, Beer D. Relevance of DNA methylation to lung cancer. In: Lung Tumors: Fundamental Biology and Clinical Management. Marcel Dekker, 1999.
13. Hanash SM. Gel Electrophoresis of Proteins: A Practical Approach. In: Two-Dimensional Gel Electrophoresis. Oxford University Press, 189-211, 1998.
14. Neel JV, Asakawa J, Kuick R, Hanash SM, and Satoh C. Studies on the genetic effects of the atomic bombs: Past, present and future. In: Effects of Ionizing Radiation: Atomic Bomb Survivors and Their Children (1945-1995). Joseph Henry Press, 159-175, 1998.
15. Satoh C, Kodaira M, Asakawa J, Takahashi N, Kuick R, Hanash SM, and Neel JV. Techniques for detecting the genetic effects of the atomic bombings applicable to the study of the genetic effects of natural radiation. In: High Levels of Radiation 1996 Radiation Dose and Health Effects. Elsevier Science B.V, 385-390, 1997.
16. Hanash SM, Richardson B, Kuick R, Wimmer K, Thoraval DH, Lamb B, Nambu Y, and Beer D. DNA methylation changes in lung cancer. In: Clinical and Biological Basis of Lung Cancer Prevention. Birkhauser Verlag Basel, 157-167, 1997.
17. Hanash SM, Ungar D, and Strahler JR. Differentation and proliferation related expression of the heat shock protein hsp27, a novel marker in cancer. In: Biologie Prospective, Comptes rendus du 8e Colloque de Pont-a-Mousson. John Libbey Eurotext, 645-650, 1993.
18. Hanash SM, Richard B, and Beer D. Revelance of DNA methylation to lung cancer in Lung. In: Fundamental Biology and Clinical Management, 1992.
19. Strahler JR, Kuick R, Piviorotto S, Somerlot L, Chu EH, and Hanash SM. High Resolution Two-Dimensional Polycrylamide Gel Electrophoresis of Mutant Polypeptides Using Narrow Range Immobilized pH Gradients in the First Dimension. In: Progress in Two-Dimensional Electrophoresis. Verlag Chemie, 256-262, 1989.
20. Teichroew D, Hanash SM, Kuick R, Ting J, Beaver A. A Strategy for the Design of a Laboratory Information Processing System for 2D Gel Studies. In: Progress in Two-Dimensional Electrophoresis. Verlag Chemie, 37-52, 1989.
21. Strahler JR, Kuick R, Hanash SM. Protein Structure: A Practical Approach. In: Two-Dimensional Electrophoresis. IRL Press, 65-92, 1989.
22. Neel JV, Strahler JR, Hanash SM, Kuick R, Chu EH. 2-D PAGE and Genetic Monitoring:Progress, Prospects, and Problems. In: Progress in Two-Dimensional Electrophoresis. Verlag Chemie, 79-89, 1989.
23. Eckerskorn C, Strahler J, Hanash SM, and Lottpeich F. Identification and Characterization of Proteins After 2-D Electrophoresis by Microsequence Analysis Demonstrated with Leukemia Protein Markers. In: Progress in Two_Dimensional Electrophoresis. Verlag Chemie, 157, 1989.
24. Chu EH, Boehnke M, Hanash SM, Kuick R, Neel JV, Strahler JR. Human somatic mutation rates in vitro. In: Proc. XVI Intern. Genome, 1988.
25. Hanash SM. Contribution of Protein Electrophoretic Analysis to Cancer Research. In: Advances in Electrophoresis, 1-44, 1988.
26. Hanash SM. A New Generation of Polypeptide Markers in Leukemia. In: Electrophoresis Forum. Proceedings, 106-113, 1987.
27. Hanash SM. Clinical Applications for Two-Dimensional Electrophoresis. Problems and Promises. In: Progress in Two-Dimensional Electrophoresis. Masson Inc, 197-204, 1986.
28. Kuick, R, Hanash SM, Sing, CF. An Interactive Multigel Matching Strategy with an Application to Multiple Tissues. In: Progress in Two-Dimensional Electrophoresis. Masson, Inc, 91-96, 1986.
29. Hanash SM. Second Dimension in Two-Dimensional Electrophoresis. In: Progress in Two-Dimensional Electrophoresis. Masson, Inc, 38-46, 1986.
30. Boerwinkle E, Sing CF, Hanash SM, Siest, G. The Analysis of Genetic Variability Using Two-Dimensional Electrophoresis. In: The Analysis of Genetic Variability Using Two-Dimensional Electrophoresis. Masson, Inc, 149-157, 1986.
31. Rosenblum, BB, Strahler, JR, Hanash SM, Whitten, CF, Butkunas, R, Roberts, A. Peripheral Blood Erythroid Progenitors from patients with Sickle Cell Anemia: HPLC Separation of Hemoglobins and the Effect of a HbF Switching Factor. In: Experimental Approches for the Study of Hemoglobins Switching. Alan R. Liss, Inc, 397-410, 1985.
32. Hanash SM, Gagnon, M, Seeger, RC. Analysis of Neuroblastoma Cell Proteins Using Two-Dimensional Electrophoresis. In: Advances in Neuroblastoma. Alan R. Liss, Inc, 261-268, 1985.
33. Strahler, JR, Rosenblum, BB, Hanash SM. Hemoglobin Beirut (val-ala) Synthesis in Erythroid Cultures. In: Protides of Biological Fluids. Pergamon, 1157-1160, 1985.
34. Rosenblum, BB, Hanash SM. Two-Dimensional Gel Analysis of Proteins in Mature Erythroid Bursts,IN. In: Electrophoresis '83. DeGruyter and Co, 180-186, 1984.
35. Neel, JV, Rosenblum, BB, Sing, CF, Skolnick, MM, Hanash SM, Sternberg A, S. Adapting Two-Dimensional Gel Electrophoresis to the Study of Human Germ-Line Mutation Rates. In: Two-Dimensional Gel Electrophoresis of Protein, Methods and Applications. Academic Press, 259-306, 1984.
36. Hanash SM, Baier, LJ, Schwartz, S. Polypeptides Differences Between T-lymphocytes and T-lymphoblasts Detected by by Two-Dimensional Electrophoresis. In: Electrophoresis '83. DeGruyter and Co, 203-210, 1984.
37. Baier, LJ, Hanash SM, Erickson, RP. Mouse Liver Protein Variants Detected by Two-Dimensional Electrophoresis. In: Electrophoresis '83. DeGruyter and CO, 350-357, 1984.
38. Aster, JC, Rosenblum, BB, Brewer, GJ, and Hanash SM. Erythrocyte Membranes: Recent Clinical and Experimental Advances. In: Analysis of Protein 4.1 Structural Variation Using Two-Dimensional Polyacrylamide Gel Electrophoresis. Alan R. Liss inc, 73-88, 1984.
39. Aster, JC, Rosenblum, BB, Brewer, G, Hanash SM. Analysis of Protein 4.1 Structural Variation Two-Dimensional Polyacrylamide Gel Electrophoresis. In: The Red Cell Membrane. Alan R. Liss, Inc, 60-68, 1984.
40. Rosenblum, BB, Hanash SM, Neel A, JV. Application to Genetic Analysis. In: High Resolution Separation of Plasma Protiens. Fifth Int. Prospective Biology Colloquium, 85-90, 1983.
41. Rahim-Pour, A, Steinmetz, J, Hanash SM. Proceedings, IVth Int. In: Separation of Plasma Lipoprotein Fractions by Two-Dimensional Electrophoresis. Prospective Biology Colloquium, 91-94, 1983.
42. Neel, JV, Mohrenweiser, H, Hanash SM, Rosenblum, BB, Sternberg, S, Wurzinger, K, Rothman, E, Satoh, C, Goriki, K, Krasteff, T, Long, M, Skolnick, M, Krzesicki, k R. Utilization of Mammalian Specific Locus Studies in Hazard Evaluation and Estimation of Genetic Risk. In: Approches to Monitoring Human Population of Germinal Mutation Rates:. Plenum Press, 71-93, 1983.
43. Hanash SM, Kavadella, M, Amanullah, A, Scheller, K, Bunnell, K. Advances in Hemoglobin Analysis. In: High Performance Liquid Chromatography of Hemoglobins: Factors Affecting Resolution. Alan R. Liss, Inc, 53-67, 1981.
44. Rucknagel, DL, Ladu, CS, Reynolds, FJ, Hanash SM, Whitten A, CF. Advances in Hemoglobin Analysis. In: Immunologic Quantitation of Fetal Hemoglobin in Sickle Cell Anemia. Alan R. Liss Inc, 94-99, 1981.
45. Hanash SM, Rucknagel A, DL. Advances in Hematology. In: Clinical Implications of Recent Advances in Hemoglobin Disorders. Med. Clini North Ameri.,64, 776-800, 1980.
46. Winter, WP, Rucknagel, DL, and Hanash SM. Advances in Human Genetics. In: Genetic Mechanisms Contributing to the Expression of Human Hemoglobin Loci. Harris, H. and HirschornK, 229-291, 1979.
47. Rucknagel DL, Hanash SM, Sing CF, Winter WP, Whitten CF, and Prasad AS. In: Age and Sex Effects of Hemoglobin F in Sickle Cell Anemia in Celluar and Molecular Regulation of Hemoglobin Switching. Grune and Stratton, 107-118, 1978.
48. Rucknagel DL, Baine RM, Hanash SM, and Winter WP. Proc. XVI Int. Conference on Hematology. In: Polymorphism in the Number of Hemoglobin Alpha Chain. Red Cell Structure and Metabolism, Alan R Liss, Inc, 63-73, 1978.
49. Rucknagel DL, Baine R, Hanash SM, and Winter W. Proc. XVI Int. Congress of Hematology. In: Dosage of Hemoglobin Alpha Chain Genes and Regulation of Hemoglobin Syntheis. Excerpta Medica, Amsterdam, 174-176, 1976.
50. Winter WP, Rucknagel DL, and Hanash SM. Proc. XVI Int. Congress of Hematology. In: Heat denaturation and degradation of hemoglobin. Excerpta Medica, Amsterdam, 307-309, 1976.
51. Hanash SM, Taguchi A. Cancer Proteomics. In: Molecular Oncology: Causes of Cancer and Targets for Treatment, 52-57.

Patents

1. Hanash, Samir M, Brichory, Franck. Detection and treatment of cancers of the lung. Patent Number: 7,202,045.
2. Nam, Myeong, Madoz-Gurpide, Juan, Wang, Hong, Misek, David E, Hanash, Samir M. Detection and treatment of cancers of the colon. Patent Number: 7,319,010.
3. Hanash, Samir M, Beretta, Laura, LeNaour, Francois. Detection and treatment of cancers of the liver. Patent Number: 7,387,881.
4. Hanash, Samir M, Rickman, David, Tyagi, Rachana, Zhu, Xiao-Xiang, Kish, Phillip. Treatments and markers for cancers of the central nervous system. Patent Number: 6,680,172.
5. Hanash S. Methods for the detection and treatment of lung cancer. Patent Number: 62456729 MDA REF 0025101.
6. Hanash, Samir M, Misek, David, Hinderer, Robert, Prasannan, Latha. Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum. Patent Number: 6,677,128.
7. Hanash, Samir M, Misek, David, Hinderer, Robert, Beer, David, Brichory, Franck. Annexin proteins and autoantibodies as serum markers for cancer. Patent Number: 7,759,081.
8. Hanash S. Methods for the detection and treatment of pancreatic cancer. Patent Number: MDA17-008.